| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transmembrane transporter activity | ATP7A SLC38A5 PANX1 SLC39A8 RYR2 RYR3 ABCB1 GJA1 SLC9B1 NALCN ABCD3 ATP6V1C2 GJB7 ANO2 SLC25A41 RHBG ATP13A1 CLIC4 SLC1A7 SLC2A1 SLC8A1 SLC9A5 SLC12A4 SLC16A3 AP4M1 CDH17 GABRA4 SLC16A10 | 6.07e-05 | 1180 | 213 | 28 | GO:0022857 |
| GeneOntologyMolecularFunction | transporter activity | ATP7A SLC38A5 PANX1 SLC39A8 RYR2 RYR3 ABCB1 GJA1 SLC9B1 NALCN ABCD3 ATP6V1C2 GJB7 ANO2 SLC25A41 RHBG ATP13A1 CLIC4 APOB SLC1A7 SLC2A1 SLC8A1 SLC9A5 SLC12A4 SLC16A3 AP4M1 CDH17 GABRA4 SLC16A10 | 1.13e-04 | 1289 | 213 | 29 | GO:0005215 |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | ATP7A SLC38A5 SLC39A8 ABCB1 SLC9B1 ABCD3 ATP6V1C2 ATP13A1 SLC1A7 SLC8A1 SLC9A5 SLC12A4 SLC16A3 CDH17 SLC16A10 | 1.96e-04 | 477 | 213 | 15 | GO:0022804 |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | SLC38A5 PANX1 SLC39A8 ABCB1 GJA1 ABCD3 SLC25A41 SLC1A7 SLC2A1 SLC16A3 SLC16A10 | 3.24e-04 | 293 | 213 | 11 | GO:0008514 |
| GeneOntologyMolecularFunction | alanine-glyoxylate transaminase activity | 3.37e-04 | 3 | 213 | 2 | GO:0008453 | |
| GeneOntologyMolecularFunction | adenosine-phosphate deaminase activity | 3.37e-04 | 3 | 213 | 2 | GO:0047623 | |
| GeneOntologyMolecularFunction | AMP deaminase activity | 3.37e-04 | 3 | 213 | 2 | GO:0003876 | |
| GeneOntologyMolecularFunction | active monoatomic ion transmembrane transporter activity | ATP7A SLC38A5 SLC39A8 SLC9B1 ATP6V1C2 ATP13A1 SLC1A7 SLC8A1 SLC9A5 SLC12A4 SLC16A3 | 4.07e-04 | 301 | 213 | 11 | GO:0022853 |
| GeneOntologyMolecularFunction | scaffold protein binding | 4.84e-04 | 93 | 213 | 6 | GO:0097110 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | ATP7A SLC38A5 PANX1 SLC39A8 RYR2 RYR3 SLC9B1 NALCN ATP6V1C2 ANO2 RHBG ATP13A1 CLIC4 SLC1A7 SLC8A1 SLC9A5 SLC12A4 SLC16A3 GABRA4 | 5.12e-04 | 758 | 213 | 19 | GO:0015318 |
| GeneOntologyMolecularFunction | sodium:proton antiporter activity | 6.05e-04 | 16 | 213 | 3 | GO:0015385 | |
| GeneOntologyMolecularFunction | ryanodine-sensitive calcium-release channel activity | 6.70e-04 | 4 | 213 | 2 | GO:0005219 | |
| GeneOntologyBiologicalProcess | positive regulation of the force of heart contraction | 1.05e-05 | 5 | 212 | 3 | GO:0098735 | |
| GeneOntologyCellularComponent | basolateral plasma membrane | ATP7A PTK2 SLC39A8 IQGAP1 DSTYK EZR RASGRF1 RHBG CASR SLC2A1 MSN SLC8A1 SLC16A3 CDH17 SLC16A10 | 1.23e-06 | 320 | 215 | 15 | GO:0016323 |
| GeneOntologyCellularComponent | basal plasma membrane | ATP7A PTK2 SLC39A8 IQGAP1 DSTYK EZR RASGRF1 RHBG CASR SLC2A1 MSN SLC8A1 SLC16A3 CDH17 SLC16A10 | 4.24e-06 | 354 | 215 | 15 | GO:0009925 |
| GeneOntologyCellularComponent | basal part of cell | ATP7A PTK2 SLC39A8 IQGAP1 DSTYK EZR RASGRF1 RHBG CASR SLC2A1 MSN SLC8A1 SLC16A3 CDH17 SLC16A10 | 9.32e-06 | 378 | 215 | 15 | GO:0045178 |
| GeneOntologyCellularComponent | apical part of cell | ATP7A MYO6 MPDZ PTK2 SLC39A8 IQGAP1 ABCB1 GJA1 DSTYK PLD1 EZR CLIC4 CASR SLC2A1 MSN SLC16A3 CYP4F3 | 1.42e-04 | 592 | 215 | 17 | GO:0045177 |
| GeneOntologyCellularComponent | apical plasma membrane | ATP7A MPDZ PTK2 SLC39A8 IQGAP1 ABCB1 GJA1 DSTYK PLD1 EZR CASR SLC2A1 MSN SLC16A3 CYP4F3 | 1.66e-04 | 487 | 215 | 15 | GO:0016324 |
| GeneOntologyCellularComponent | lysosome | SERPINA3 MYO6 NCF4 SLC39A8 BPI RRAGD AP2A2 SYT11 VPS13A ATP6V1C2 PLD1 NOS1 SFTPD APOB USP5 SNX14 SPPL2A SLC12A4 LNPEP CCT8 | 2.83e-04 | 811 | 215 | 20 | GO:0005764 |
| GeneOntologyCellularComponent | lytic vacuole | SERPINA3 MYO6 NCF4 SLC39A8 BPI RRAGD AP2A2 SYT11 VPS13A ATP6V1C2 PLD1 NOS1 SFTPD APOB USP5 SNX14 SPPL2A SLC12A4 LNPEP CCT8 | 2.83e-04 | 811 | 215 | 20 | GO:0000323 |
| GeneOntologyCellularComponent | postsynapse | CELF4 ATP7A ATR KIF1A MYO6 KIF1B NAPA MPDZ RPS26 BCR PTK2 CYFIP1 AP2A2 SYT11 NOS1 SLC1A7 SNX14 SLC8A1 SLC9A5 SLC16A3 ARHGEF2 SMCR8 GABRA4 | 3.46e-04 | 1018 | 215 | 23 | GO:0098794 |
| GeneOntologyCellularComponent | platelet alpha granule | 4.00e-04 | 93 | 215 | 6 | GO:0031091 | |
| GeneOntologyCellularComponent | vacuole | SERPINA3 MYO6 NCF4 TTC3 SLC39A8 BPI RRAGD AP2A2 SYT11 VPS13A ATP6V1C2 PLD1 NOS1 SFTPD APOB USP5 SNX14 SPPL2A SLC12A4 LNPEP CCT8 | 5.01e-04 | 913 | 215 | 21 | GO:0005773 |
| GeneOntologyCellularComponent | platelet alpha granule lumen | 6.32e-04 | 67 | 215 | 5 | GO:0031093 | |
| GeneOntologyCellularComponent | vesicle lumen | SERPINA3 F13A1 CYFIP1 BPI VPS13A ALB AMPD3 VWF APOB CCT8 PROS1 | 6.82e-04 | 332 | 215 | 11 | GO:0031983 |
| GeneOntologyCellularComponent | blood microparticle | 7.38e-04 | 144 | 215 | 7 | GO:0072562 | |
| GeneOntologyCellularComponent | sarcolemma | 8.07e-04 | 190 | 215 | 8 | GO:0042383 | |
| GeneOntologyCellularComponent | sarcoplasmic reticulum membrane | 1.17e-03 | 45 | 215 | 4 | GO:0033017 | |
| GeneOntologyCellularComponent | replication fork | 1.19e-03 | 77 | 215 | 5 | GO:0005657 | |
| GeneOntologyCellularComponent | cell-cell junction | MPDZ PANX1 PTK2 IQGAP1 ABCB1 GJA1 GJB7 EZR CLIC4 PTPRU SLC2A1 MSN SLC8A1 ARHGEF2 CDH17 | 1.24e-03 | 591 | 215 | 15 | GO:0005911 |
| Domain | Lipase_euk | 2.66e-05 | 6 | 208 | 3 | IPR025483 | |
| Domain | Abhydro_lipase | 2.66e-05 | 6 | 208 | 3 | PF04083 | |
| Domain | AB_hydrolase_lipase | 2.66e-05 | 6 | 208 | 3 | IPR006693 | |
| Domain | ARM-type_fold | ATR FMNL2 ARMCX1 RYR3 URB1 NF1 AP2A2 XPO4 APOB FRYL WDFY4 FMNL3 SF3B1 LTA4H | 2.82e-05 | 339 | 208 | 14 | IPR016024 |
| Domain | Cell_morpho_N | 1.23e-04 | 2 | 208 | 2 | IPR025614 | |
| Domain | Cell_Morphogen_C | 1.23e-04 | 2 | 208 | 2 | IPR025481 | |
| Domain | MOR2-PAG1_mid | 1.23e-04 | 2 | 208 | 2 | IPR029473 | |
| Domain | MOR2-PAG1_mid | 1.23e-04 | 2 | 208 | 2 | PF14228 | |
| Domain | MOR2-PAG1_C | 1.23e-04 | 2 | 208 | 2 | PF14225 | |
| Domain | MOR2-PAG1_N | 1.23e-04 | 2 | 208 | 2 | PF14222 | |
| Domain | Ubiquitinyl_hydrolase | 1.23e-04 | 2 | 208 | 2 | IPR016652 | |
| Domain | RB_A | 3.68e-04 | 3 | 208 | 2 | IPR002720 | |
| Domain | DUF3452 | 3.68e-04 | 3 | 208 | 2 | PF11934 | |
| Domain | RB_B | 3.68e-04 | 3 | 208 | 2 | IPR002719 | |
| Domain | AMPD | 3.68e-04 | 3 | 208 | 2 | IPR006329 | |
| Domain | RB_C | 3.68e-04 | 3 | 208 | 2 | IPR015030 | |
| Domain | Ryanodine_rcpt | 3.68e-04 | 3 | 208 | 2 | IPR003032 | |
| Domain | RB_fam | 3.68e-04 | 3 | 208 | 2 | IPR028309 | |
| Domain | RB_N | 3.68e-04 | 3 | 208 | 2 | IPR024599 | |
| Domain | Ryanrecept_TM4-6 | 3.68e-04 | 3 | 208 | 2 | IPR009460 | |
| Domain | RB_A | 3.68e-04 | 3 | 208 | 2 | PF01858 | |
| Domain | RB_B | 3.68e-04 | 3 | 208 | 2 | PF01857 | |
| Domain | RyR | 3.68e-04 | 3 | 208 | 2 | PF02026 | |
| Domain | RR_TM4-6 | 3.68e-04 | 3 | 208 | 2 | PF06459 | |
| Domain | DUF3452 | 3.68e-04 | 3 | 208 | 2 | SM01367 | |
| Domain | Rb_C | 3.68e-04 | 3 | 208 | 2 | SM01369 | |
| Domain | RB_A | 3.68e-04 | 3 | 208 | 2 | SM01368 | |
| Domain | Ryan_recept | 3.68e-04 | 3 | 208 | 2 | IPR013333 | |
| Domain | ERM_C_dom | 7.30e-04 | 4 | 208 | 2 | IPR011259 | |
| Domain | Kinesin-like_KIF1-typ | 7.30e-04 | 4 | 208 | 2 | IPR022140 | |
| Domain | Pecanex_C | 7.30e-04 | 4 | 208 | 2 | PF05041 | |
| Domain | KIF1B | 7.30e-04 | 4 | 208 | 2 | PF12423 | |
| Domain | ERM | 7.30e-04 | 4 | 208 | 2 | PF00769 | |
| Domain | Pecanex | 7.30e-04 | 4 | 208 | 2 | IPR007735 | |
| Domain | A/AMP_deam_AS | 7.30e-04 | 4 | 208 | 2 | IPR006650 | |
| Domain | ERM | 7.30e-04 | 4 | 208 | 2 | IPR011174 | |
| Domain | GDS_CDC24_CS | 9.06e-04 | 39 | 208 | 4 | IPR001331 | |
| Domain | PH_dom-like | KIF1A KIF1B TBC1D2B BCR PTK2 PTPN13 PLD1 EZR RASGRF1 WDFY4 PREX2 MSN ARHGEF2 | 1.02e-03 | 426 | 208 | 13 | IPR011993 |
| Domain | FERM_M | 1.69e-03 | 46 | 208 | 4 | PF00373 | |
| Domain | RIH_assoc-dom | 1.80e-03 | 6 | 208 | 2 | IPR013662 | |
| Domain | Kinesin_assoc | 1.80e-03 | 6 | 208 | 2 | PF16183 | |
| Domain | A_DEAMINASE | 1.80e-03 | 6 | 208 | 2 | PS00485 | |
| Domain | Ins145_P3_rec | 1.80e-03 | 6 | 208 | 2 | PF08709 | |
| Domain | Kinesin-like | 1.80e-03 | 6 | 208 | 2 | IPR022164 | |
| Domain | RIH_assoc | 1.80e-03 | 6 | 208 | 2 | PF08454 | |
| Domain | A_deaminase | 1.80e-03 | 6 | 208 | 2 | PF00962 | |
| Domain | RIH_dom | 1.80e-03 | 6 | 208 | 2 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 1.80e-03 | 6 | 208 | 2 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 1.80e-03 | 6 | 208 | 2 | IPR015925 | |
| Domain | Kinesin_assoc | 1.80e-03 | 6 | 208 | 2 | IPR032405 | |
| Domain | - | 1.80e-03 | 6 | 208 | 2 | 1.25.10.30 | |
| Domain | RYDR_ITPR | 1.80e-03 | 6 | 208 | 2 | PF01365 | |
| Domain | DUF3694 | 1.80e-03 | 6 | 208 | 2 | PF12473 | |
| Domain | A/AMP_deaminase_dom | 1.80e-03 | 6 | 208 | 2 | IPR001365 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | ATP7A SLC38A5 SLC39A8 RYR2 RYR3 ABCB1 MICU1 SLC9B1 AP2A2 NALCN ABCD3 ALB ATP6V1C2 ANO2 RHBG ATP13A1 APOB SLC1A7 SLC2A1 SLC8A1 SLC9A5 SLC12A4 SLC16A3 SLC16A10 | 1.59e-06 | 681 | 167 | 24 | MM14985 |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | ATP7A SLC38A5 SLC39A8 RYR2 RYR3 ABCB1 MICU1 SLC9B1 AP2A2 NALCN ABCD3 ALB ATP6V1C2 ANO2 RHBG ATP13A1 APOB SLC1A7 SLC2A1 SLC8A1 SLC9A5 SLC12A4 SLC16A3 SLC16A10 | 6.07e-06 | 736 | 167 | 24 | M27287 |
| Pathway | PID_RAC1_REG_PATHWAY | 8.04e-05 | 38 | 167 | 5 | M241 | |
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | GALNT1 GINM1 ATR LGR4 NAPA L2HGDH COG3 GJA1 NF1 VPS13A ANKIB1 TIMELESS GNPAT EZR TMEM248 TMEM41A ATP13A1 ST7 PRXL2A APOB PPA1 PIGU MSN ORC4 SLC12A4 ARHGEF2 CDH17 PROS1 | 1.33e-10 | 1061 | 216 | 28 | 33845483 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | SETD1A MYO6 MCM6 MIDEAS ARMCX1 NT5DC1 PTK2 IQGAP1 URB1 CYFIP1 NF1 AP2A2 A2ML1 ABCD3 ANKIB1 HACD3 CLIC4 PPA1 SLC2A1 MSN MSH6 USP5 SF3B1 PRIM2 NUP133 CCT8 PDCD11 ARHGEF2 RPA1 ALDH7A1 | 1.70e-09 | 1353 | 216 | 30 | 29467282 |
| Pubmed | Comparative interactome analysis of α-arrestin families in human and Drosophila. | PDXDC1 SETD1A MYO6 BCR FMNL2 ABCB1 PTPN13 NF1 ABCD3 ANKIB1 SLC2A1 FMNL3 USP5 ARHGEF2 | 1.21e-08 | 313 | 216 | 14 | 38270169 |
| Pubmed | Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma. | PDXDC1 ATP7A MYO6 PANX1 IQGAP1 PTPN13 CYFIP1 NF1 SYT11 EZR MSN FMNL3 PACS1 SLC12A4 SLC16A3 | 1.71e-08 | 377 | 216 | 15 | 38117590 |
| Pubmed | MYO6 L2HGDH NBN MCM6 RPS26 HMCES HACD3 PPA1 YARS1 ORC4 MSH6 USP5 SF3B1 PRIM2 NUP133 LTA4H RPA1 | 4.90e-08 | 534 | 216 | 17 | 35032548 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | HIVEP1 ATR KIF1A MYO6 MCM6 RPS26 TTC3 IQGAP1 URB1 CYFIP1 NF1 AP2A2 ABCD3 TMEM117 EZR HACD3 ATP13A1 HAT1 APOB PPA1 SLC2A1 YARS1 MSH6 SF3B1 NUP133 CCT8 PDCD11 RPA1 | 7.98e-08 | 1425 | 216 | 28 | 30948266 |
| Pubmed | PDXDC1 MYO6 NAPA L2HGDH NBN MCM6 TUBGCP4 IQGAP1 CYFIP1 AP2A2 ABCD3 TIMELESS GNPAT HAT1 PAF1 MSH6 NUP133 | 9.65e-08 | 560 | 216 | 17 | 35241646 | |
| Pubmed | PDXDC1 ATP7A ACACB MYO6 KIF1B LGR4 NDRG3 FMNL2 RYR2 PTPN13 VPS13A ABCD3 ALB PLD1 APOB ARHGAP1 SF3B1 CCT8 AP4M1 SMCR8 | 1.02e-07 | 777 | 216 | 20 | 35844135 | |
| Pubmed | PDXDC1 ATP7A KIF1A ZFYVE16 COG3 CDKAL1 PTPN13 VPS13A ABCD3 PLD1 ST7 PIGU SNX14 SLC12A4 LNPEP SMCR8 | 1.28e-07 | 504 | 216 | 16 | 34432599 | |
| Pubmed | KIF1A MYO6 KIF1B BACH1 NAPA TTC3 FMNL2 PTK2 RYR3 IQGAP1 MICU1 NAA25 PTPN13 STAMBPL1 EZR USP13 VWF ATP13A1 RBL2 CLIC4 YARS1 ARHGAP1 FRY SF3B1 YLPM1 ANKRD36 | 1.38e-07 | 1285 | 216 | 26 | 35914814 | |
| Pubmed | NBS1 mediates ATR-dependent RPA hyperphosphorylation following replication-fork stall and collapse. | 2.36e-07 | 3 | 216 | 3 | 18003706 | |
| Pubmed | GALNT1 URB1 PTPN13 TMEM181 HACD3 ATP13A1 AGPAT2 APOB PIGU SF3B1 PDCD11 ARHGEF2 | 3.90e-07 | 296 | 216 | 12 | 34186245 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | KIF1B NAPA MCM6 RPS26 ENOPH1 IQGAP1 NAA25 CYFIP1 A2ML1 EZR AMPD1 HAT1 CLIC4 FRYL PPA1 SLC2A1 MSN ARHGAP1 MSH6 USP5 SF3B1 YLPM1 CCT8 PDCD11 LTA4H ALDH7A1 | 4.48e-07 | 1367 | 216 | 26 | 32687490 |
| Pubmed | Interpreting cancer genomes using systematic host network perturbations by tumour virus proteins. | CDKAL1 GJA1 AP2A2 TMEM181 HACD3 ATP13A1 RBL1 RBL2 APOB PIGU SLC2A1 SNX14 SLC12A4 SLC16A3 ENG | 6.33e-07 | 499 | 216 | 15 | 22810586 |
| Pubmed | ATP7A MYO6 BACH1 MPDZ NBN TTC3 CDKAL1 MICU1 DNAJB13 GJA1 URB1 PTPN13 VPS13A ABCD3 SCO1 HACD3 ATP13A1 ST7 PAF1 PIGU SLC2A1 ARHGAP1 SF3B1 LNPEP NUP133 PDCD11 SMCR8 | 6.50e-07 | 1487 | 216 | 27 | 33957083 | |
| Pubmed | ATR MPDZ L2HGDH TUBGCP4 BCR PTK2 DSTYK ABCD3 ANKIB1 TIMELESS GNPAT USP13 RBL1 MSN PACS1 ARHGEF2 CMTR2 | 7.71e-07 | 650 | 216 | 17 | 38777146 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | PDXDC1 KIF1A ZFYVE16 CD109 MPDZ MCM6 BCR CDKAL1 CYFIP1 ABCD3 SCO1 HACD3 DUSP6 XPO4 PTPRU ARHGAP1 MSH6 USP5 LNPEP NUP133 CCT8 | 8.74e-07 | 974 | 216 | 21 | 28675297 |
| Pubmed | MYO6 TTC21A KIF1B RPS26 BCR FMNL2 IQGAP1 GJA1 CYFIP1 NF1 AP2A2 ABCD3 ALB DNAH6 NOS1 VWF HACD3 SLC2A1 YARS1 PACS1 USP5 AGO1 SF3B1 CCT8 ARHGEF2 ALDH7A1 | 1.05e-06 | 1431 | 216 | 26 | 37142655 | |
| Pubmed | ATR NBN MCM6 NT5DC1 IQGAP1 JMJD6 USP13 HAT1 PPA1 PAF1 YARS1 MSN MSH6 USP5 SF3B1 PRIM2 YLPM1 NUP133 CCT8 LTA4H RPA1 | 1.65e-06 | 1014 | 216 | 21 | 32416067 | |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | KIF1A MPDZ TUBGCP4 PTK2 IQGAP1 NF1 SYT11 A2ML1 ALB EZR PREX2 MSN FRY AGO1 | 1.90e-06 | 475 | 216 | 14 | 31040226 |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | GALNT1 GINM1 ATR CD109 LGR4 SLC38A5 NT5DC1 CDKAL1 GJA1 NF1 TIMELESS TMEM248 HACD3 AGPAT2 PRXL2A PIGU USP5 SNX14 SLC16A3 LNPEP CCT8 ENG PROS1 | 1.93e-06 | 1201 | 216 | 23 | 35696571 |
| Pubmed | 2.34e-06 | 5 | 216 | 3 | 10198040 | ||
| Pubmed | ATP7A ZFYVE16 MYO6 KIF1B MPDZ CDKAL1 IQGAP1 PTPN13 CYFIP1 ABCD3 EZR HACD3 MSN ARHGAP1 CCT8 RPA1 SMCR8 | 2.45e-06 | 708 | 216 | 17 | 39231216 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | TTC21A KIF1B BACH1 MCM6 TUBGCP4 BCR FMNL2 IQGAP1 MICU1 PTPN13 CYFIP1 NF1 AP2A2 ABCD3 SCO1 EZR RBL1 AGPAT2 XPO4 PPA1 PIGU PACS1 NUP133 RPA1 | 2.83e-06 | 1321 | 216 | 24 | 27173435 |
| Pubmed | MPDZ TTC3 BCR PTK2 IQGAP1 CYFIP1 NF1 AP2A2 NOS1 EZR PAF1 MSN FRY AGO1 SF3B1 ZNF516 YLPM1 CCT8 ARHGEF2 RPA1 | 2.83e-06 | 963 | 216 | 20 | 28671696 | |
| Pubmed | CD109 NAPA L2HGDH RPS26 TUBGCP4 COG3 CDKAL1 IQGAP1 GJA1 URB1 AP2A2 ABCD3 HACD3 ST7 AGPAT2 XPO4 HAT1 MSH6 USP5 SF3B1 NUP133 CCT8 PDCD11 ARHGEF2 RPA1 | 3.84e-06 | 1440 | 216 | 25 | 30833792 | |
| Pubmed | PDXDC1 RPS26 TUBGCP4 NF1 VPS13A ABCD3 HACD3 XPO4 PIGU SLC2A1 YARS1 MSH6 SF3B1 NUP133 PCNX1 SLC16A10 | 4.08e-06 | 657 | 216 | 16 | 36180527 | |
| Pubmed | GALNT1 LGR4 TTC3 NT5DC1 F13A1 URB1 PTPN13 RRAGD TIMELESS PLD1 TMEM181 EZR TMEM248 APOB FRYL COX18 WDFY4 SLC2A1 ORC4 PACS1 RPA1 | 4.65e-06 | 1084 | 216 | 21 | 11544199 | |
| Pubmed | 4.66e-06 | 6 | 216 | 3 | 15975910 | ||
| Pubmed | MMS19 assembles iron-sulfur proteins required for DNA metabolism and genomic integrity. | 4.80e-06 | 150 | 216 | 8 | 22678362 | |
| Pubmed | HIVEP1 ZFYVE16 MYO6 TTC3 FMNL2 RYR2 AP2A2 USP13 VWF FMNL3 USP5 SF3B1 SLC12A4 LNPEP YLPM1 | 5.03e-06 | 591 | 216 | 15 | 15231748 | |
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | SERPINA3 MYO6 NAPA ADGRV1 BCR NDRG3 IQGAP1 ABCB1 PTPN13 BPI ALB ATP6V1C2 VWF RBL2 CLIC4 MSN ARHGAP1 CCT8 LTA4H AP4M1 | 6.27e-06 | 1016 | 216 | 20 | 19056867 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | HIVEP1 ATR KIF1B BACH1 NBN IQGAP1 NF1 TIMELESS HACD3 PACS1 MSH6 SF3B1 ZNF516 YLPM1 ELK3 ARHGEF2 CDH17 | 7.90e-06 | 774 | 216 | 17 | 15302935 |
| Pubmed | 8.12e-06 | 7 | 216 | 3 | 20233725 | ||
| Pubmed | 8.12e-06 | 7 | 216 | 3 | 15124025 | ||
| Pubmed | BRIT1 regulates early DNA damage response, chromosomal integrity, and cancer. | 8.12e-06 | 7 | 216 | 3 | 16872911 | |
| Pubmed | 8.12e-06 | 7 | 216 | 3 | 17526493 | ||
| Pubmed | 8.12e-06 | 7 | 216 | 3 | 24990965 | ||
| Pubmed | 8.12e-06 | 7 | 216 | 3 | 33537097 | ||
| Pubmed | FAM105A/OTULINL Is a Pseudodeubiquitinase of the OTU-Class that Localizes to the ER Membrane. | PDXDC1 NAPA PANX1 CDKAL1 VPS13A ATP13A1 ST7 PRXL2A PIGU ARHGAP1 SLC12A4 LNPEP SMCR8 | 8.40e-06 | 468 | 216 | 13 | 31056421 |
| Pubmed | 8.81e-06 | 215 | 216 | 9 | 30462309 | ||
| Pubmed | PDXDC1 ATP7A MYO6 COG3 CDKAL1 GJA1 PTPN13 HACD3 ATP13A1 PRXL2A CLIC4 SLC2A1 MSN ARHGAP1 SLC12A4 LNPEP NUP133 SMCR8 SLC16A10 | 8.90e-06 | 952 | 216 | 19 | 38569033 | |
| Pubmed | The human plasma proteome: a nonredundant list developed by combination of four separate sources. | 9.68e-06 | 165 | 216 | 8 | 14718574 | |
| Pubmed | ZFYVE16 NBN PTPN13 VPS13A ABCD3 ST7 DUSP6 XPO4 PTPRU PAF1 ARHGAP1 PACS1 MSH6 SLC12A4 LNPEP PRIM2 YLPM1 NUP133 ARHGEF2 RPA1 | 9.98e-06 | 1049 | 216 | 20 | 27880917 | |
| Pubmed | PDXDC1 ACACB ZFYVE16 TBC1D2B PTK2 CDKAL1 CLIC4 ARHGAP1 SLC16A3 LNPEP SMCR8 | 1.01e-05 | 339 | 216 | 11 | 37232246 | |
| Pubmed | ZFYVE16 MYO6 MPDZ NBN MCM6 RPS26 BCR HSP90AA5P IQGAP1 AP2A2 ABCD3 HACD3 HAT1 PAF1 ORC4 MSH6 SF3B1 PRIM2 CCT8 PCNX1 ARHGEF2 RPA1 ALDH7A1 | 1.09e-05 | 1335 | 216 | 23 | 29229926 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | MYO6 MPDZ MCM6 RPS26 IQGAP1 CYFIP1 AP2A2 EZR HAT1 CLIC4 PPA1 PAF1 YARS1 MSN MSH6 USP5 SF3B1 CCT8 LTA4H RPA1 ALDH7A1 | 1.12e-05 | 1149 | 216 | 21 | 35446349 |
| Pubmed | HIVEP1 ACACB MYO6 NBN RYR2 CYFIP1 NF1 VPS13A PPP2R3C AMPD1 PIGU ZNF516 ARHGEF2 SMCR8 CDH17 | 1.24e-05 | 638 | 216 | 15 | 31182584 | |
| Pubmed | Organ size control is dominant over Rb family inactivation to restrict proliferation in vivo. | 1.29e-05 | 8 | 216 | 3 | 25017070 | |
| Pubmed | 1.29e-05 | 8 | 216 | 3 | 10793131 | ||
| Pubmed | 1.29e-05 | 8 | 216 | 3 | 12086466 | ||
| Pubmed | 1.39e-05 | 24 | 216 | 4 | 31740596 | ||
| Pubmed | Genetic susceptibility to distinct bladder cancer subphenotypes. | 1.45e-05 | 421 | 216 | 12 | 19692168 | |
| Pubmed | 1.54e-05 | 127 | 216 | 7 | 30442766 | ||
| Pubmed | KIF1A MCM6 RPS26 IQGAP1 URB1 NF1 FRYL MSN MSH6 USP5 SF3B1 YLPM1 NUP133 PDCD11 LTA4H | 1.63e-05 | 653 | 216 | 15 | 22586326 | |
| Pubmed | Characterization of the interactome of the human MutL homologues MLH1, PMS1, and PMS2. | 1.78e-05 | 87 | 216 | 6 | 17148452 | |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | HIVEP1 MYO6 MPDZ MCM6 TMEM104 BCR IQGAP1 MICU1 ABCD3 ALB STAMBPL1 EZR NEPRO USP13 HAT1 USP5 PRIM2 YLPM1 ARHGEF2 | 1.88e-05 | 1005 | 216 | 19 | 19615732 |
| Pubmed | 1.93e-05 | 9 | 216 | 3 | 9535855 | ||
| Pubmed | MET Inhibitors Promote Liver Tumor Evasion of the Immune Response by Stabilizing PDL1. | 1.97e-05 | 182 | 216 | 8 | 30711629 | |
| Pubmed | PEX14 is required for microtubule-based peroxisome motility in human cells. | 2.18e-05 | 54 | 216 | 5 | 21525035 | |
| Pubmed | 5-HT(6) receptor recruitment of mTOR as a mechanism for perturbed cognition in schizophrenia. | 2.27e-05 | 27 | 216 | 4 | 23027611 | |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | MYO6 MCM6 RPS26 HSP90AA5P CYFIP1 SCO1 DNAH6 EZR HACD3 HAT1 PAF1 SLC2A1 MSN MSH6 USP5 SF3B1 CCT8 | 2.50e-05 | 847 | 216 | 17 | 35235311 |
| Pubmed | 2.60e-05 | 93 | 216 | 6 | 22079093 | ||
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | PDXDC1 GALNT1 KIF1A MYO6 MCM6 CDKAL1 IQGAP1 GJA1 URB1 NAA25 ABCD3 TIMELESS HACD3 ATP13A1 HAT1 USP5 NUP133 ARHGEF2 | 2.74e-05 | 942 | 216 | 18 | 31073040 |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | SETD1A ACACB MCM6 RPS26 CDKAL1 AP2A2 JMJD6 ABCD3 ALB HACD3 HAT1 PPA1 PAF1 SLC2A1 YARS1 ORC4 MSH6 SF3B1 CCT8 PDCD11 ARHGEF2 RPA1 | 2.75e-05 | 1318 | 216 | 22 | 30463901 |
| Pubmed | 3.31e-05 | 143 | 216 | 7 | 20424473 | ||
| Pubmed | New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules. | ATR KIF1A TUBGCP4 TTC3 RYR2 AP2A2 PLD1 PACS1 FRY AGO1 YLPM1 GABRA4 | 3.61e-05 | 462 | 216 | 12 | 31138677 |
| Pubmed | Early expression of p107 is associated with 3T3-L1 adipocyte differentiation. | 3.84e-05 | 2 | 216 | 2 | 12242027 | |
| Pubmed | Revisiting the human polypeptide GalNAc-T1 and T13 paralogs. | 3.84e-05 | 2 | 216 | 2 | 27913570 | |
| Pubmed | 3.84e-05 | 2 | 216 | 2 | 37144518 | ||
| Pubmed | 3.84e-05 | 2 | 216 | 2 | 8898078 | ||
| Pubmed | 3.84e-05 | 2 | 216 | 2 | 17371490 | ||
| Pubmed | 3.84e-05 | 2 | 216 | 2 | 14550562 | ||
| Pubmed | Loss of the mammalian DREAM complex deregulates chondrocyte proliferation. | 3.84e-05 | 2 | 216 | 2 | 24710275 | |
| Pubmed | 3.84e-05 | 2 | 216 | 2 | 32260308 | ||
| Pubmed | Ryanodine receptor 2 promotes colorectal cancer metastasis by the ROS/BACH1 axis. | 3.84e-05 | 2 | 216 | 2 | 36453019 | |
| Pubmed | 3.84e-05 | 2 | 216 | 2 | 16537896 | ||
| Pubmed | 3.84e-05 | 2 | 216 | 2 | 11689484 | ||
| Pubmed | 3.84e-05 | 2 | 216 | 2 | 11689483 | ||
| Pubmed | Moesin: a member of the protein 4.1-talin-ezrin family of proteins. | 3.84e-05 | 2 | 216 | 2 | 1924289 | |
| Pubmed | 3.84e-05 | 2 | 216 | 2 | 24516351 | ||
| Pubmed | 3.84e-05 | 2 | 216 | 2 | 18409530 | ||
| Pubmed | Altered ryanodine receptor expression in mild cognitive impairment and Alzheimer's disease. | 3.84e-05 | 2 | 216 | 2 | 21531043 | |
| Pubmed | 3.84e-05 | 2 | 216 | 2 | 16678258 | ||
| Pubmed | Expression of p107 and p130 during human adipose-derived stem cell adipogenesis. | 3.84e-05 | 2 | 216 | 2 | 18086563 | |
| Pubmed | Cx43 Hemichannel and Panx1 Channel Modulation by Gap19 and 10Panx1 Peptides. | 3.84e-05 | 2 | 216 | 2 | 37511370 | |
| Pubmed | Alternative splicing in the Atp7a gene in the Cu deficient mosaic mutation in mice. | 3.84e-05 | 2 | 216 | 2 | 19058563 | |
| Pubmed | 3.84e-05 | 2 | 216 | 2 | 20603190 | ||
| Pubmed | 3.84e-05 | 2 | 216 | 2 | 9747874 | ||
| Pubmed | 3.84e-05 | 2 | 216 | 2 | 1903516 | ||
| Pubmed | 3.84e-05 | 2 | 216 | 2 | 22456474 | ||
| Pubmed | 3.84e-05 | 2 | 216 | 2 | 28327544 | ||
| Pubmed | 3.84e-05 | 2 | 216 | 2 | 12213808 | ||
| Pubmed | 3.84e-05 | 2 | 216 | 2 | 11468295 | ||
| Pubmed | 3.84e-05 | 2 | 216 | 2 | 12543870 | ||
| Pubmed | 3.84e-05 | 2 | 216 | 2 | 30337665 | ||
| Pubmed | RyR2 regulates Cx43 hemichannel intracellular Ca2+-dependent activation in cardiomyocytes. | 3.84e-05 | 2 | 216 | 2 | 31841141 | |
| Pubmed | Pannexin 1 involvement in bladder dysfunction in a multiple sclerosis model. | 3.84e-05 | 2 | 216 | 2 | 23827947 | |
| Pubmed | 3.84e-05 | 2 | 216 | 2 | 18945966 | ||
| Pubmed | 3.84e-05 | 2 | 216 | 2 | 15616588 | ||
| Interaction | RHOA interactions | PDXDC1 ATP7A MYO6 LGR4 NAPA SLC38A5 PANX1 BCR FMNL2 CDKAL1 IQGAP1 GJA1 PTPN13 CYFIP1 NF1 AP2A2 VPS13A ABCD3 SCO1 PLD1 EZR RASGRF1 HACD3 ATP13A1 ST7 FRYL PPA1 PIGU SLC2A1 PREX2 YARS1 MSN FMNL3 ARHGAP1 SLC12A4 SLC16A3 LNPEP PDCD11 ARHGEF2 RPA1 SMCR8 | 1.45e-11 | 1199 | 211 | 41 | int:RHOA |
| Interaction | RAC1 interactions | ATP7A ZFYVE16 MYO6 TBC1D2B LGR4 SLC38A5 PANX1 BCR FMNL2 PTK2 IQGAP1 GJA1 PTPN13 CYFIP1 NF1 AP2A2 VPS13A PLD1 EZR VWF RASGRF1 HACD3 ATP13A1 PPA1 SLC2A1 PREX2 YARS1 ARHGAP1 PACS1 SLC12A4 SLC16A3 LNPEP ARHGEF2 RPA1 IMMP2L | 1.54e-09 | 1063 | 211 | 35 | int:RAC1 |
| Interaction | RAC3 interactions | PDXDC1 ATP7A ZFYVE16 TBC1D2B LGR4 SLC38A5 PANX1 CDKAL1 IQGAP1 GJA1 PTPN13 CYFIP1 NF1 VPS13A ABCD3 HACD3 FRYL PPA1 SLC2A1 ARHGAP1 SLC12A4 SLC16A3 LNPEP | 1.56e-07 | 619 | 211 | 23 | int:RAC3 |
| Interaction | RAB35 interactions | PDXDC1 ATP7A TBC1D2B PANX1 NDRG3 FMNL2 CDKAL1 IQGAP1 GJA1 PTPN13 CYFIP1 VPS13A ABCD3 PLD1 GNPAT SLC2A1 ARHGAP1 SLC12A4 LNPEP RPA1 SMCR8 | 6.97e-07 | 573 | 211 | 21 | int:RAB35 |
| Interaction | GJD3 interactions | PDXDC1 ATP7A ZFYVE16 MYO6 COG3 FMNL2 CDKAL1 GJA1 PTPN13 PLD1 HACD3 ATP13A1 ST7 PIGU SLC2A1 ARHGAP1 LNPEP SMCR8 | 1.50e-06 | 454 | 211 | 18 | int:GJD3 |
| Interaction | MCAM interactions | PDXDC1 ATP7A MYO6 PANX1 FMNL2 HSP90AA5P IQGAP1 GJA1 PTPN13 CYFIP1 NF1 SYT11 EZR MSN FMNL3 PACS1 SLC12A4 SLC16A3 | 2.31e-06 | 468 | 211 | 18 | int:MCAM |
| Interaction | RAC2 interactions | PDXDC1 ZFYVE16 MYO6 NAPA PANX1 CDKAL1 IQGAP1 GJA1 CYFIP1 VPS13A ABCD3 PLD1 HACD3 PPA1 PIGU SLC2A1 FMNL3 ARHGAP1 USP5 SLC12A4 SLC16A3 LNPEP | 2.53e-06 | 674 | 211 | 22 | int:RAC2 |
| Interaction | RND2 interactions | PDXDC1 MYO6 TBC1D2B MCM6 CDKAL1 GJA1 PTPN13 CYFIP1 VPS13A ABCD3 PPA1 SLC2A1 YARS1 ARHGAP1 SLC12A4 LNPEP SMCR8 | 4.19e-06 | 440 | 211 | 17 | int:RND2 |
| Interaction | RHOQ interactions | ZFYVE16 PANX1 IQGAP1 ABCB1 GJA1 PTPN13 NF1 RRAGD AP2A2 VPS13A PLD1 PPA1 SLC2A1 ARHGAP1 SLC12A4 LNPEP SMCR8 | 4.45e-06 | 442 | 211 | 17 | int:RHOQ |
| Interaction | IFITM1 interactions | PDXDC1 KIF1A ZFYVE16 MYO6 NAPA AP2A2 SYT11 APOB PPA1 YARS1 ARHGAP1 LNPEP AP4M1 RPA1 SMCR8 | 5.40e-06 | 355 | 211 | 15 | int:IFITM1 |
| Interaction | RHOB interactions | ATP7A ZFYVE16 MYO6 TBC1D2B SLC38A5 PANX1 BCR FMNL2 IQGAP1 GJA1 PTPN13 CYFIP1 NF1 VPS13A PLD1 HACD3 PPA1 SLC2A1 MSN ARHGAP1 SLC12A4 SLC16A3 LNPEP ARHGEF2 | 8.44e-06 | 840 | 211 | 24 | int:RHOB |
| Interaction | RHOF interactions | PDXDC1 ATP7A ATR MYO6 SLC38A5 MPDZ PANX1 IQGAP1 NAA25 PTPN13 CYFIP1 VPS13A HACD3 SLC2A1 YARS1 ARHGAP1 GSTT1 PACS1 SLC12A4 SLC16A3 LNPEP | 8.64e-06 | 673 | 211 | 21 | int:RHOF |
| Interaction | RHOG interactions | PDXDC1 ZFYVE16 TBC1D2B SLC38A5 PANX1 CDKAL1 IQGAP1 GJA1 CYFIP1 RRAGD VPS13A ABCD3 SCO1 PLD1 ST7 PIGU SLC2A1 PREX2 ARHGAP1 PACS1 SLC12A4 SLC16A3 LNPEP RPA1 SMCR8 | 1.06e-05 | 910 | 211 | 25 | int:RHOG |
| Interaction | RHOC interactions | ATP7A LGR4 PANX1 BCR FMNL2 CDKAL1 IQGAP1 GJA1 PTPN13 CYFIP1 VPS13A ABCD3 HACD3 PPA1 PIGU SLC2A1 ARHGAP1 SLC12A4 LNPEP | 1.33e-05 | 584 | 211 | 19 | int:RHOC |
| Interaction | RAB5C interactions | ATP7A GINM1 ZFYVE16 SLC38A5 TTC3 CDKAL1 GJA1 DSTYK VPS13A ABCD3 PLD1 ATP13A1 DUSP6 SLC2A1 ARHGAP1 SLC12A4 LNPEP RPA1 SMCR8 | 1.93e-05 | 600 | 211 | 19 | int:RAB5C |
| Interaction | RAB11A interactions | PDXDC1 SERPINA3 ACACB ATR ZFYVE16 TBC1D2B NAPA PANX1 CDKAL1 ABCB1 VPS13A ABCD3 PLD1 CLIC4 SLC2A1 ARHGAP1 SLC12A4 SLC16A3 LNPEP NUP133 PDCD11 RPA1 SMCR8 | 2.14e-05 | 830 | 211 | 23 | int:RAB11A |
| Interaction | RHOH interactions | MYO6 MCM6 PANX1 CDKAL1 GJA1 PTPN13 CYFIP1 VPS13A ABCD3 HACD3 PPA1 SLC2A1 YARS1 ARHGAP1 SLC12A4 LNPEP SMCR8 | 2.97e-05 | 512 | 211 | 17 | int:RHOH |
| Interaction | RHOD interactions | PDXDC1 MYO6 SLC38A5 MCM6 FMNL2 CDKAL1 IQGAP1 PTPN13 CYFIP1 VPS13A ABCD3 HACD3 PPA1 SLC2A1 ARHGAP1 SLC12A4 SLC16A3 LNPEP | 3.49e-05 | 572 | 211 | 18 | int:RHOD |
| Interaction | GPR17 interactions | PDXDC1 ATR TUBGCP4 COG3 GJA1 URB1 NAA25 DSTYK TIMELESS PRXL2A XPO4 PIGU | 4.62e-05 | 283 | 211 | 12 | int:GPR17 |
| Interaction | CDC42 interactions | PDXDC1 ATR MYO6 MCM6 PANX1 BCR FMNL2 CDKAL1 IQGAP1 GJA1 PTPN13 CYFIP1 NF1 AP2A2 VPS13A ABCD3 SCO1 PLD1 HACD3 FRYL PPA1 SLC2A1 PREX2 YARS1 FMNL3 ARHGAP1 SLC12A4 SLC16A3 LNPEP RPA1 | 5.25e-05 | 1323 | 211 | 30 | int:CDC42 |
| Interaction | LAMP3 interactions | PDXDC1 ATP7A KIF1A ZFYVE16 FMNL2 CDKAL1 ABCB1 GJA1 DSTYK PLD1 ATP13A1 SLC2A1 ARHGAP1 SLC12A4 LNPEP SMCR8 | 5.66e-05 | 486 | 211 | 16 | int:LAMP3 |
| Interaction | RAB9A interactions | PDXDC1 KIF1A ZFYVE16 MYO6 KIF1B NAPA CDKAL1 RRAGD VPS13A ABCD3 PLD1 HACD3 SLC2A1 ARHGAP1 SNX14 LNPEP PDCD11 SMCR8 | 5.81e-05 | 595 | 211 | 18 | int:RAB9A |
| Interaction | BRF2 interactions | 7.45e-05 | 42 | 211 | 5 | int:BRF2 | |
| Interaction | AP2A1 interactions | MYO6 BCR IQGAP1 CYFIP1 AP2A2 GJB7 EZR SLC25A41 WDFY4 PACS1 SF3B1 RPA1 | 7.83e-05 | 299 | 211 | 12 | int:AP2A1 |
| Interaction | PHF11 interactions | 9.95e-05 | 137 | 211 | 8 | int:PHF11 | |
| Interaction | RAB2A interactions | PDXDC1 ATP7A BCR FMNL2 IQGAP1 GJA1 GARIN4 VPS13A ABCD3 STAMBPL1 PLD1 SLC25A41 SLC2A1 ARHGAP1 SLC12A4 LNPEP RPA1 | 1.04e-04 | 567 | 211 | 17 | int:RAB2A |
| Interaction | EED interactions | PDXDC1 ACACB MYO6 BACH1 NAPA MCM6 RPS26 IQGAP1 GJA1 URB1 NAA25 CYFIP1 AP2A2 ABCD3 ALB EZR SFTPD RBL1 XPO4 SLC2A1 FMNL3 ARHGAP1 MSH6 USP5 SF3B1 ZNF516 YLPM1 NUP133 CCT8 PDCD11 RPA1 | 1.08e-04 | 1445 | 211 | 31 | int:EED |
| Interaction | ARF6 interactions | MYO6 COG3 FMNL2 CDKAL1 IQGAP1 GJA1 CYFIP1 ABCD3 PLD1 EZR ATP13A1 SLC2A1 YARS1 ARHGAP1 SLC12A4 LNPEP RPA1 | 1.48e-04 | 584 | 211 | 17 | int:ARF6 |
| Interaction | LAMP1 interactions | PDXDC1 ATP7A ZFYVE16 CDKAL1 IQGAP1 GJA1 PTPN13 CYFIP1 AP2A2 PLD1 HACD3 ATP13A1 SLC2A1 ARHGAP1 ORC4 LNPEP RPA1 SLC16A10 | 1.57e-04 | 644 | 211 | 18 | int:LAMP1 |
| Cytoband | 10q23.31 | 1.98e-05 | 34 | 216 | 4 | 10q23.31 | |
| Cytoband | 6q21-q22 | 6.59e-05 | 3 | 216 | 2 | 6q21-q22 | |
| GeneFamily | Solute carriers | SLC38A5 SLC39A8 SLC9B1 SLC25A41 RHBG SLC1A7 SLC2A1 SLC8A1 SLC9A5 SLC12A4 SLC16A3 SLC16A10 | 1.08e-04 | 395 | 149 | 12 | 752 |
| GeneFamily | Ryanodine receptors|Protein phosphatase 1 regulatory subunits | 2.01e-04 | 3 | 149 | 2 | 287 | |
| GeneFamily | Polypeptide N-acetylgalactosaminyltransferases | 5.64e-04 | 20 | 149 | 3 | 433 | |
| GeneFamily | Lipases|Arylacetamide deacetylase family | 7.53e-04 | 22 | 149 | 3 | 464 | |
| GeneFamily | Ankyrin repeat domain containing|FERM domain containing | 7.60e-04 | 50 | 149 | 4 | 1293 | |
| GeneFamily | Adenosine deaminase family | 9.90e-04 | 6 | 149 | 2 | 1302 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 2.15e-03 | 66 | 149 | 4 | 722 | |
| GeneFamily | C3 and PZP like, alpha-2-macroglobulin domain containing | 2.34e-03 | 9 | 149 | 2 | 1234 | |
| Coexpression | GSE17721_CTRL_VS_CPG_24H_BMDC_UP | CELF4 KIF1A L2HGDH CDKAL1 DNAJB13 DSTYK CYP4F3 AP4M1 IMMP2L CDH17 | 5.97e-06 | 200 | 213 | 10 | M3771 |
| Coexpression | GSE17721_CTRL_VS_LPS_0.5H_BMDC_UP | KIF1A MPDZ L2HGDH DSTYK HAT1 HTRA3 MLXIP CYP4F3 AP4M1 IMMP2L | 5.97e-06 | 200 | 213 | 10 | M3679 |
| Coexpression | GSE25890_CTRL_VS_IL33_IL7_TREATED_NUOCYTES_DN | NBN TUBGCP4 COG3 URB1 LIPT2 TMEM248 AGPAT2 COX18 ORC4 NUP133 | 5.97e-06 | 200 | 213 | 10 | M7356 |
| Coexpression | CUI_TCF21_TARGETS_2_DN | HIVEP1 ATP7A GINM1 ZFYVE16 MYO6 KIF1B FMNL2 ARMCX1 ABCB1 MICU1 DSTYK VPS13A PLD1 DUSP6 FRYL PREX2 FRY LNPEP ST6GALNAC3 PROS1 GABRA4 | 7.13e-06 | 854 | 213 | 21 | M1533 |
| Coexpression | CUI_TCF21_TARGETS_2_DN | HIVEP1 ATP7A GINM1 ZFYVE16 MYO6 KIF1B FMNL2 ARMCX1 ABCB1 MICU1 DSTYK VPS13A PLD1 DUSP6 FRYL PREX2 FRY LNPEP ST6GALNAC3 PROS1 GABRA4 | 1.28e-05 | 888 | 213 | 21 | MM1018 |
| Coexpression | DESCARTES_ORGANOGENESIS_ENDOTHELIAL_CELLS | 1.53e-05 | 272 | 213 | 11 | MM3634 | |
| Coexpression | FAN_EMBRYONIC_CTX_BRAIN_ENDOTHELIAL_1 | MYO6 SLC38A5 BCR SLC39A8 ABCB1 GJA1 VWF PRXL2A CLIC4 PPA1 SLC2A1 PREX2 FRY ENG | 1.63e-05 | 440 | 213 | 14 | M39039 |
| Coexpression | GSE15659_TREG_VS_TCONV_UP | 3.04e-05 | 193 | 213 | 9 | M3534 | |
| Coexpression | PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_1 | 3.53e-05 | 46 | 213 | 5 | M2407 | |
| Coexpression | GSE31082_CD4_VS_CD8_SP_THYMOCYTE_DN | 3.87e-05 | 199 | 213 | 9 | M5070 | |
| Coexpression | GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_IL12_CD8_TCELL_DN | 4.02e-05 | 200 | 213 | 9 | M3610 | |
| Coexpression | GSE2770_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_2H_UP | 4.02e-05 | 200 | 213 | 9 | M6090 | |
| Coexpression | GSE40666_NAIVE_VS_EFFECTOR_CD8_TCELL_WITH_IFNA_STIM_90MIN_DN | 4.02e-05 | 200 | 213 | 9 | M9211 | |
| Coexpression | GSE20715_0H_VS_24H_OZONE_LUNG_UP | SLC38A5 NCF4 ARMCX1 FMNL3 ARHGAP1 PACS1 ELK3 ARHGEF2 ALDH7A1 | 4.02e-05 | 200 | 213 | 9 | M4366 |
| Coexpression | LAKE_ADULT_KIDNEY_C2_PODOCYTES | 6.32e-05 | 212 | 213 | 9 | M39221 | |
| Coexpression | DURAND_STROMA_NS_UP | 7.60e-05 | 169 | 213 | 8 | M2582 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP | ATR KIF1B NBN MCM6 CDKAL1 MICU1 ABCD3 PPP2R3C RBL1 HAT1 CLIC4 FRYL SLC2A1 MSH6 LNPEP CCT8 | 8.10e-05 | 644 | 213 | 16 | M10501 |
| Coexpression | TRAVAGLINI_LUNG_OLR1_CLASSICAL_MONOCYTE_CELL | BACH1 NBN RPS26 SLC39A8 IQGAP1 CYFIP1 DPYD AMPD3 DUSP6 CLIC4 MSN SPPL2A SLC16A3 PCNX1 ELK3 ENG SLC16A10 | 9.62e-05 | 724 | 213 | 17 | M41700 |
| Coexpression | LAKE_ADULT_KIDNEY_C4_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S2 | 1.01e-04 | 176 | 213 | 8 | M39223 | |
| Coexpression | GSE12505_WT_VS_E2_2_HET_PDC_UP | 1.01e-04 | 131 | 213 | 7 | M437 | |
| Coexpression | FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN | PDXDC1 BACH1 NBN ARMCX1 F13A1 SLC39A8 ALMS1 AP2A2 CMKLR2 PPA1 SLC8A1 LPAR6 LTA4H | 1.04e-04 | 458 | 213 | 13 | M4785 |
| Coexpression | GSE37533_PPARG1_FOXP3_VS_PPARG2_FOXP3_TRANSDUCED_CD4_TCELL_UP | 1.09e-04 | 178 | 213 | 8 | M8996 | |
| Coexpression | ASTIER_INTEGRIN_SIGNALING | 1.09e-04 | 58 | 213 | 5 | M3590 | |
| Coexpression | KASLER_HDAC7_TARGETS_1_UP | 1.84e-04 | 192 | 213 | 8 | M2317 | |
| Coexpression | DURAND_STROMA_NS_UP | 1.97e-04 | 194 | 213 | 8 | MM962 | |
| Coexpression | KASLER_HDAC7_TARGETS_1_UP | 1.97e-04 | 194 | 213 | 8 | MM910 | |
| Coexpression | FAN_EMBRYONIC_CTX_BIG_GROUPS_BRAIN_ENDOTHELIAL | MYO6 SLC38A5 SLC39A8 IQGAP1 ABCB1 VWF DUSP6 PRXL2A CLIC4 SLC2A1 ENG | 2.13e-04 | 365 | 213 | 11 | M39018 |
| Coexpression | SENESE_HDAC3_TARGETS_UP | MYO6 BACH1 FMNL2 CDKAL1 IQGAP1 NF1 PLD1 EZR PCDHB15 SF3B1 SLC12A4 PCNX4 ELK3 | 2.23e-04 | 495 | 213 | 13 | M8451 |
| Coexpression | GSE40274_XBP1_VS_FOXP3_AND_XBP1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN | 2.26e-04 | 198 | 213 | 8 | M9163 | |
| Coexpression | GSE8835_HEALTHY_VS_CLL_CD4_TCELL_UP | 2.34e-04 | 199 | 213 | 8 | M6260 | |
| Coexpression | GSE25123_WT_VS_PPARG_KO_MACROPHAGE_UP | 2.34e-04 | 199 | 213 | 8 | M7951 | |
| Coexpression | GSE4984_GALECTIN1_VS_VEHICLE_CTRL_TREATED_DC_DN | 2.34e-04 | 199 | 213 | 8 | M6507 | |
| Coexpression | ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_1DY_DN | MGAT4A TTC3 NDRG3 NT5DC1 ABCB1 VPS13A TMEM181 NEPRO USP13 HACD3 RBL1 RBL2 TLR10 FMNL3 ZFAND1 PACS1 PCNX1 LTA4H RPA1 SLC16A10 | 2.39e-04 | 1012 | 213 | 20 | M40864 |
| Coexpression | GSE41867_NAIVE_VS_EFFECTOR_CD8_TCELL_DN | 2.42e-04 | 200 | 213 | 8 | M9475 | |
| Coexpression | GSE41867_LCMV_ARMSTRONG_VS_CLONE13_DAY8_EFFECTOR_CD8_TCELL_UP | 2.42e-04 | 200 | 213 | 8 | M9478 | |
| Coexpression | GSE41867_NAIVE_VS_DAY6_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_DN | 2.42e-04 | 200 | 213 | 8 | M9496 | |
| Coexpression | GSE369_PRE_VS_POST_IL6_INJECTION_IFNG_KO_LIVER_DN | 2.42e-04 | 200 | 213 | 8 | M5975 | |
| Coexpression | GSE16385_ROSIGLITAZONE_IL4_VS_IFNG_TNF_STIM_MACROPHAGE_UP | 2.42e-04 | 200 | 213 | 8 | M8030 | |
| Coexpression | GSE36826_NORMAL_VS_STAPH_AUREUS_INF_SKIN_DN | 2.42e-04 | 200 | 213 | 8 | M9535 | |
| Coexpression | GSE1460_INTRATHYMIC_T_PROGENITOR_VS_NAIVE_CD4_TCELL_ADULT_BLOOD_UP | 2.42e-04 | 200 | 213 | 8 | M3446 | |
| Coexpression | GSE17721_LPS_VS_POLYIC_1H_BMDC_UP | 2.42e-04 | 200 | 213 | 8 | M3798 | |
| Coexpression | GSE15930_STIM_VS_STIM_AND_IL12_48H_CD8_T_CELL_UP | 2.42e-04 | 200 | 213 | 8 | M3629 | |
| Coexpression | GSE15930_STIM_VS_STIM_AND_TRICHOSTATINA_48H_CD8_T_CELL_DN | 2.42e-04 | 200 | 213 | 8 | M3638 | |
| Coexpression | GSE12392_WT_VS_IFNB_KO_CD8A_NEG_SPLEEN_DC_DN | 2.42e-04 | 200 | 213 | 8 | M7150 | |
| Coexpression | GSE46606_DAY1_VS_DAY3_CD40L_IL2_IL5_STIMULATED_IRF4HIGH_BCELL_DN | 2.42e-04 | 200 | 213 | 8 | M9839 | |
| Coexpression | GSE30962_PRIMARY_VS_SECONDARY_CHRONIC_LCMV_INF_CD8_TCELL_DN | 2.42e-04 | 200 | 213 | 8 | M5045 | |
| Coexpression | GSE22432_PDC_VS_TGFB1_TREATEDCOMMON_DC_PROGENITOR_DN | 2.42e-04 | 200 | 213 | 8 | M7833 | |
| Coexpression | GSE3982_BASOPHIL_VS_EFF_MEMORY_CD4_TCELL_UP | 2.42e-04 | 200 | 213 | 8 | M5556 | |
| Coexpression | GSE40666_WT_VS_STAT1_KO_CD8_TCELL_UP | 2.42e-04 | 200 | 213 | 8 | M9205 | |
| Coexpression | GSE40274_FOXP3_VS_FOXP3_AND_GATA1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP | 2.42e-04 | 200 | 213 | 8 | M9186 | |
| Coexpression | GSE7831_UNSTIM_VS_CPG_STIM_PDC_4H_DN | 2.42e-04 | 200 | 213 | 8 | M6954 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C7_SST_POS_NEURON_CELL | CELF4 ATP7A PLPPR3 RYR2 ABCB1 NALCN STAMBPL1 TG FRY SLC8A1 SLC16A3 | 2.68e-04 | 375 | 213 | 11 | M45799 |
| Coexpression | GSE37532_VISCERAL_ADIPOSE_TISSUE_VS_LN_DERIVED_TREG_CD4_TCELL_DN | 2.86e-04 | 155 | 213 | 7 | M8944 | |
| Coexpression | LU_AGING_BRAIN_UP | 3.19e-04 | 263 | 213 | 9 | M5547 | |
| Coexpression | KIM_HYPOXIA | 3.31e-04 | 17 | 213 | 3 | M1496 | |
| Coexpression | BURTON_ADIPOGENESIS_PEAK_AT_16HR | 3.39e-04 | 41 | 213 | 4 | M1681 | |
| CoexpressionAtlas | kidney_adult_RenMedVasc_Tie2_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.27e-05 | 80 | 206 | 7 | gudmap_kidney_adult_RenMedVasc_Tie2_k3_1000 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | MYO6 SLC38A5 MPDZ BCR IQGAP1 ABCB1 ANO2 VWF CLIC4 SLC2A1 PREX2 FRY | 3.05e-10 | 200 | 216 | 12 | 032df80aa5c40991e1c1e80f9d8da106e6aeaee2 |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN---|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | MYO6 SLC38A5 MPDZ BCR IQGAP1 ABCB1 ANO2 VWF CLIC4 SLC2A1 PREX2 FRY | 3.05e-10 | 200 | 216 | 12 | 68fce28690246895fd33354b30960ebcc31aa4cc |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN----L2-6|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | MYO6 SLC38A5 MPDZ BCR IQGAP1 ABCB1 ANO2 VWF CLIC4 SLC2A1 PREX2 FRY | 3.05e-10 | 200 | 216 | 12 | 878bbbe32e3602723aa14ef32877ab2453b8c6e5 |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN-|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | MYO6 SLC38A5 MPDZ BCR IQGAP1 ABCB1 ANO2 VWF CLIC4 SLC2A1 PREX2 FRY | 3.05e-10 | 200 | 216 | 12 | 376b19ab5a7cd2c85f726d8ba41337d4525863e5 |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN--|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | MYO6 SLC38A5 MPDZ BCR IQGAP1 ABCB1 ANO2 VWF CLIC4 SLC2A1 PREX2 FRY | 3.05e-10 | 200 | 216 | 12 | 7fa54370221ed61bac0e09e6bcf1f3dff202a846 |
| ToppCell | Hematolymphoid-Endothelial|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | MYO6 SLC38A5 MPDZ BCR IQGAP1 ABCB1 ANO2 VWF CLIC4 SLC2A1 PREX2 FRY | 3.05e-10 | 200 | 216 | 12 | 7136936d05ab344a560cf159684c881063b5430d |
| ToppCell | COVID-19-kidney-VWF+PLVAP+EC|kidney / Disease (COVID-19 only), tissue and cell type | 4.43e-08 | 196 | 216 | 10 | b71b197cb92117dd9efaa13de000841901cc4ca8 | |
| ToppCell | mild-unassigned|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | BCR SLC9B1 NAA25 PTPN13 AP2A2 SYT11 USP13 CASP5 YLPM1 NUP133 | 5.36e-08 | 200 | 216 | 10 | ca0a08bf162c954f037a56aa0cbb8b5d7c6ffec0 |
| ToppCell | Ionocyte|World / Class top | ATP7A GALNT13 IQGAP1 ACSM3 RRAGD PDILT ATP6V1C2 TMEM117 HACD3 | 1.55e-07 | 170 | 216 | 9 | d2e592f2a679e6a8d32f2b752d9a3c493e50ced4 |
| ToppCell | 3'_v3-GI_small-bowel-Myeloid_Dendritic-DC1|GI_small-bowel / Manually curated celltypes from each tissue | 3.03e-07 | 184 | 216 | 9 | 8e393eea7240584a3cef718bee094e2705ec1891 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | ADGRV1 SLC39A8 GALNT13 PTPN13 ABCD3 MACC1 SFTPD LTA4H IMMP2L | 3.63e-07 | 188 | 216 | 9 | 4bdf8d49af0e9da349b16e3f012e1b0eec04cc4f |
| ToppCell | RA-08._Macrophage|World / Chamber and Cluster_Paper | 4.53e-07 | 193 | 216 | 9 | 5fd22db1825d105709fcc0aa4955c99a117e3c82 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.94e-07 | 195 | 216 | 9 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | COVID-19-kidney-PLVAP+EC|kidney / Disease (COVID-19 only), tissue and cell type | 4.94e-07 | 195 | 216 | 9 | a436483fec137584611f86b7a498a4dc2aa19cd3 | |
| ToppCell | LV-09._Endothelium_I|World / Chamber and Cluster_Paper | 4.94e-07 | 195 | 216 | 9 | 19e0a6c3eae1615aaa39767300acd937dfcb2a7f | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.94e-07 | 195 | 216 | 9 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.16e-07 | 196 | 216 | 9 | 8ad8efb631164b46f0c082572270188e5ead20bf | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.16e-07 | 196 | 216 | 9 | 9606ea7e42f707e69ea891b3521037613b9675f5 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_immature-Tip-like-A|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.38e-07 | 197 | 216 | 9 | 9e948b2e0f7e426f1e6f95bbbf4282fbddc2b99d | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.38e-07 | 197 | 216 | 9 | cd509e49bbdbf991cc5913960ff3ef275ad40628 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.38e-07 | 197 | 216 | 9 | 412cb5f37df57121ddd1492021445479c7cbccbf | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_capilar-A|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.85e-07 | 199 | 216 | 9 | c5c12c8288fe868322bae9d691b91fee953ceb3e | |
| ToppCell | tumor_Lymph_Node_/_Brain-Myeloid_cells-mo-Mac|Myeloid_cells / Location, Cell class and cell subclass | 6.10e-07 | 200 | 216 | 9 | 195862a319794e57f0506757ae45ab70200bc5b4 | |
| ToppCell | droplet-Heart-nan-18m-Mesenchymal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.56e-06 | 166 | 216 | 8 | 9adceb746e67e955fd8b3e0984f4eed44b64a270 | |
| ToppCell | P15-Mesenchymal-mesenchymal_fibroblast-mesenchymal_progenitor_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.86e-06 | 170 | 216 | 8 | ba4ba66b624089ed50a9083176386c7941b4c7a3 | |
| ToppCell | PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.86e-06 | 170 | 216 | 8 | 4ce81608111b9ee7cb974dad2c182f38db3dcd79 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.52e-06 | 177 | 216 | 8 | 8e4005fad50e6f919da175f3b9ae58849dbd60b1 | |
| ToppCell | COVID-19-Heart-EC_3|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.23e-06 | 183 | 216 | 8 | ff95382cfed592190d0636d2b750328471f82e0d | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-alveolar_macrophage-proliferating_alveolar_macrophage|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.50e-06 | 185 | 216 | 8 | b4af9ae4c358b48357cb135b740266e1652d886a | |
| ToppCell | COVID-19-Endothelial_cells-Systemic_venous_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 3.50e-06 | 185 | 216 | 8 | f5e14181f45c37d13ee9e017a4c8bc248c353676 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.64e-06 | 186 | 216 | 8 | e83718fabb057100835d3357df407f283d23fe16 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.78e-06 | 187 | 216 | 8 | 35c382c0aabd46906113e5db30ea24bb8e658899 | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_3|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 4.26e-06 | 190 | 216 | 8 | 651a1d3ae286e40f9d9f60e438211c6148d24143 | |
| ToppCell | COVID-19-Heart-EC_3|Heart / Disease (COVID-19 only), tissue and cell type | 4.26e-06 | 190 | 216 | 8 | 78e7c502b0450c0b37652b1896a2a752fd8a2111 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.42e-06 | 191 | 216 | 8 | b2c86cde341fe350143658c8a8a4a9edbce3f19b | |
| ToppCell | COVID-19-kidney-Stressed_EC|kidney / Disease (COVID-19 only), tissue and cell type | 4.42e-06 | 191 | 216 | 8 | d35aa842b813ea0eff7362abc894cca4e86b2fb2 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.60e-06 | 192 | 216 | 8 | 3259cb89d6bcf0a3c6ff1f64d85e8a1f54124e91 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.60e-06 | 192 | 216 | 8 | 28eb3a5728e8901bcb5ba12f6b009f41b065fa37 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.60e-06 | 192 | 216 | 8 | c0e59e642b42c055cf73d029cf54d07d9b719359 | |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|LV / Chamber and Cluster_Paper | 4.60e-06 | 192 | 216 | 8 | ad19e2c1d36a0566c9b12ced10db78f4781c8ea6 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial-A|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.78e-06 | 193 | 216 | 8 | 3f8280ef849d95b2fcea5e6824b95a07febc96d0 | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.78e-06 | 193 | 216 | 8 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | RV-09._Endothelium_I|World / Chamber and Cluster_Paper | 4.78e-06 | 193 | 216 | 8 | e3fa47e2c7cd8a5b69186711c57751f2296de8ae | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Connecting_Tubule_Intercalated_Cell_Type_A|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.84e-06 | 137 | 216 | 7 | 81cdb216e6c81acf9c2072f9d39e1a42612e1258 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.96e-06 | 194 | 216 | 8 | a429d22c8c9d0fd3bfa9f877a6364cecad68db30 | |
| ToppCell | RV-09._Endothelium_I|RV / Chamber and Cluster_Paper | 4.96e-06 | 194 | 216 | 8 | 7b408096e717f2327c12aea35a8d5fc4621d3b06 | |
| ToppCell | Endothelial-endothelial_cell_of_vein|World / Lineage, Cell type, age group and donor | 4.96e-06 | 194 | 216 | 8 | 3cbd9622a68e89add90e589867d88c83c5a33476 | |
| ToppCell | LA-09._Endothelium_I|World / Chamber and Cluster_Paper | 5.15e-06 | 195 | 216 | 8 | fc95457a298b5d0dab687d9ee7e225a7f7b9a0d4 | |
| ToppCell | COVID-19-Myeloid-Monocyte-derived_macrophages|COVID-19 / group, cell type (main and fine annotations) | 5.15e-06 | 195 | 216 | 8 | c172c5599379c29123340621a36bfb1fc90c2115 | |
| ToppCell | COVID-19-Heart-EC_1|Heart / Disease (COVID-19 only), tissue and cell type | 5.15e-06 | 195 | 216 | 8 | 50a193475db1bb1e05b8590225a553688c372c14 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.15e-06 | 195 | 216 | 8 | 77e47d2e8b3eb7f7c9620369ccaf87581f923bdb | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.15e-06 | 195 | 216 | 8 | 818bc18c5834238e5f733cac6fe928ed0788f57d | |
| ToppCell | COVID_vent-Myeloid-Monocytic-Developing_Neutrophil|COVID_vent / Disease condition, Lineage, Cell class and subclass | 5.15e-06 | 195 | 216 | 8 | de23409b1b4146b8ae286850b829ec8dceed0117 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary-EC_venous_pulmonary_L.2.2.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.15e-06 | 195 | 216 | 8 | 81a98ebb0d43f416f9a8bba580531dc0cfea8f74 | |
| ToppCell | LV-09._Endothelium_I|LV / Chamber and Cluster_Paper | 5.55e-06 | 197 | 216 | 8 | f9731d4d636e51b94a96805eee6afe9aedc175e3 | |
| ToppCell | Tracheal-NucSeq-Endothelial-Endothelia_vascular-VE_capillary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.55e-06 | 197 | 216 | 8 | 31bec97c3952c48031bd66a5dad16a70a61519c3 | |
| ToppCell | nucseq-Immune-Immune_Myeloid-IM|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.55e-06 | 197 | 216 | 8 | 6f41c8f815851968849428ec92c16745bd01a3fb | |
| ToppCell | nucseq-Immune-Immune_Myeloid-IM-IM|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.55e-06 | 197 | 216 | 8 | 304044ace926943b8eb588f686ecbe5d1689a809 | |
| ToppCell | Tracheal-NucSeq-Endothelial-Endothelia_vascular-VE_systemic_venous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.76e-06 | 198 | 216 | 8 | 5c82dad416938d5c460069796d808170e7dbc8d9 | |
| ToppCell | Tracheal-NucSeq-Endothelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.76e-06 | 198 | 216 | 8 | 77e31b6edeeb5ccd5cd3f080898c96bf9ab9f98d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.76e-06 | 198 | 216 | 8 | 440af8f90c7afa1c07000806bcf9110b70f489fb | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.76e-06 | 198 | 216 | 8 | 0a172c6d997c7cfbad34b56e80121bd104dee67d | |
| ToppCell | metastatic_Brain-Endothelial_cells-Tumor_ECs|metastatic_Brain / Location, Cell class and cell subclass | 5.76e-06 | 198 | 216 | 8 | 5e274f29cc796dae7d64d6035e904816c25f9914 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_capilar-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.76e-06 | 198 | 216 | 8 | 0a4626b51ba8b52acbaf616f0ced850079cd7149 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.76e-06 | 198 | 216 | 8 | 1378c6d4ceb84b42fdd6556be3296df7a8059e6e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.76e-06 | 198 | 216 | 8 | 451003a21162eeae90739fdb502bb50b362d80c8 | |
| ToppCell | metastatic_Brain-Endothelial_cells|metastatic_Brain / Location, Cell class and cell subclass | 5.76e-06 | 198 | 216 | 8 | 97ef7946ef11ac93318c1dd46b548dc01e5a6aba | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 5.76e-06 | 198 | 216 | 8 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 5.98e-06 | 199 | 216 | 8 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | COPD-Myeloid-Macrophage|COPD / Disease state, Lineage and Cell class | 5.98e-06 | 199 | 216 | 8 | 4b9c53fb4f44190d2f6ad4d52b13be01ebe4955e | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.21e-06 | 200 | 216 | 8 | 86ec951234015ced7126b016199e5869a0f22478 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_capilar|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.21e-06 | 200 | 216 | 8 | c239e6f5d23caa9a59b83e9b352b2d6a691dcb28 | |
| ToppCell | COVID-19-COVID-19_Severe-Myeloid-immature_Neutrophil|COVID-19_Severe / Disease, condition lineage and cell class | 6.21e-06 | 200 | 216 | 8 | cbe667eda1af222467df8bfa157aa22df488f133 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.21e-06 | 200 | 216 | 8 | 061ba851f941c616ddb462512e826c412881c3ce | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Keratinizing_Cervical_Squamous_Cell_Carcinoma-3|TCGA-Cervix / Sample_Type by Project: Shred V9 | 1.13e-05 | 156 | 216 | 7 | ffb9249a115ce31f50b99a7a3d40bf48b9d7f2b0 | |
| ToppCell | PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD8_T-CD8_T_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.28e-05 | 159 | 216 | 7 | e9c51e611ebd427bbe51e3e036c14122c36ea372 | |
| ToppCell | COVID-19-kidney-Epithelial_(EC)|kidney / Disease (COVID-19 only), tissue and cell type | 1.34e-05 | 160 | 216 | 7 | 0d4880f85565d8c540c94a8f8109147b3029279a | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.45e-05 | 162 | 216 | 7 | 373513f9d0e5007b2e10a8b78d4909dcce9e3b62 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-Degenerative_Endothelial_Cell-Degenerative_Peritubular_Capilary_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.51e-05 | 163 | 216 | 7 | 73c03e29a6d7a6863c5e9aa5e8b963ef691f1ddb | |
| ToppCell | Bronchial-NucSeq-Endothelial-Endothelia_vascular-VE_systemic_arterial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.57e-05 | 164 | 216 | 7 | 3cd80e6275f0f9b5667912139d15ebf5e6b17f2f | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.83e-05 | 168 | 216 | 7 | 37249f38f8f04ec5743097259de67b106ca2b02f | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.90e-05 | 169 | 216 | 7 | c7fc3a8c44f07c557b60d469717b66e2f5863d38 | |
| ToppCell | Ionocyte-iono-1|World / Class top | 1.90e-05 | 169 | 216 | 7 | 4b68bcb4b5fc3cd2db23cd4edace7444aa2d605c | |
| ToppCell | 390C-Myeloid-Macrophage-SPP1+_Macrophage_4|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.05e-05 | 171 | 216 | 7 | 7c8304573b892ef9ea4e048cba9ea9fbab848dcd | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_artery-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.05e-05 | 171 | 216 | 7 | 1597459c971d6befa991d59dc66b41b6a522f797 | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-Proliferating_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-05 | 173 | 216 | 7 | 15af4a0f7516dbf5c93ba66a19aca073ebe30d04 | |
| ToppCell | Ionocyte-iono-2|World / Class top | 2.21e-05 | 173 | 216 | 7 | e5ec28ccc5e048fd98de4c876e5c53b866b66228 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Endothelial-lymphatic_endothelial-LEC1_(ACKR4+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.30e-05 | 174 | 216 | 7 | 4a18b51501eaaeb7907e99316ba8ae15b2c7d529 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Endothelial-endothelial_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.47e-05 | 176 | 216 | 7 | eb63eb2c301e785196ccadac74a2940b2c524c62 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.47e-05 | 176 | 216 | 7 | 5e46a09a36b9645b1b1fcb0b64bd0898561af3a9 | |
| ToppCell | 3'_v3-lymph-node_spleen-Mast-Mast_cell_lympho|lymph-node_spleen / Manually curated celltypes from each tissue | 2.56e-05 | 177 | 216 | 7 | 53040dbeb18574a48e352e4bce252c7c3018762c | |
| ToppCell | COVID-19-Heart-EC_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.75e-05 | 179 | 216 | 7 | 2a53d94f6c30bf887dfe88f1693ea057218c852d | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Endothelial-endothelial_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.06e-05 | 182 | 216 | 7 | ab5761bf9af439231cd0f487b6467e372672a517 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.06e-05 | 182 | 216 | 7 | 17ed11a7ea366dd3106400511d5e628d3f1a9c3e | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Endothelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.06e-05 | 182 | 216 | 7 | 3b4dbf61ca0fe50efe05449815630e301cb76630 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Endothelial_Myeloid-Endo|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.17e-05 | 183 | 216 | 7 | c7fc96ac1d5d31ccefe0c1fc6ec76c7d8607a172 | |
| ToppCell | 3'_v3-GI_small-bowel-Myeloid_Dendritic|GI_small-bowel / Manually curated celltypes from each tissue | 3.17e-05 | 183 | 216 | 7 | 6109199cf25b28831193a5ed7925b5bf38c6eb43 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Endothelial_Myeloid-Endo-Endothelial|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.17e-05 | 183 | 216 | 7 | 6cdadb3ece45a94a2915063aa461048e1d371ccd | |
| ToppCell | COVID-19-kidney-Mito-rich_EC|kidney / Disease (COVID-19 only), tissue and cell type | 3.17e-05 | 183 | 216 | 7 | 3c4153479fc4ab2d073d92cee120480015555914 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Endothelial_Myeloid-Endo-Endothelial-Endo_L2-5_CLDN5|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.17e-05 | 183 | 216 | 7 | 8714d3e7663c93cdf9b25b647353572e136f30c3 | |
| Drug | hydroxyl radicals | ATP7A SLC38A5 L2HGDH NCF4 CYP39A1 ENOPH1 PTK2 ABCB1 PTPN13 AP2A2 TIMELESS ALB ATP6V1C2 PLD1 MMP12 NOS1 DMGDH DPYD AMPD1 USP13 AMPD3 VWF DUSP6 LIPF PPA1 PTPRU PIGU GSTT1 USP5 LTA4H AP4M1 ALDH7A1 PROS1 | 4.22e-07 | 1341 | 215 | 33 | CID000000961 |
| Drug | NOC-9 | 1.29e-06 | 21 | 215 | 5 | CID000004524 | |
| Drug | Pronethalol hydrochloride [51-02-5]; Up 200; 15uM; MCF7; HT_HG-U133A | TMEM104 CDKAL1 NF1 NOS1 AMPD3 RBL1 RBL2 CASR SLC1A7 PACS1 ALDH7A1 | 3.05e-06 | 198 | 215 | 11 | 7322_UP |
| Drug | Thimerosal | ACACB KIF1A MYO6 PLPPR3 ADGRV1 COG3 CYP39A1 FMNL2 PTK2 RYR3 IQGAP1 NF1 SRL ALB HAT1 RASGEF1A SLC2A1 PREX2 MSN GSTT1 SLC8A1 AGO1 SF3B1 LNPEP FER1L4 PRIM2 PCNX1 LTA4H | 9.33e-06 | 1199 | 215 | 28 | ctd:D013849 |
| Drug | Pargyline hydrochloride [306-07-0]; Down 200; 20.4uM; HL60; HG-U133A | 1.45e-05 | 191 | 215 | 10 | 1418_DN | |
| Drug | Medrysone [2668-66-8]; Down 200; 11.6uM; MCF7; HT_HG-U133A | SETD1A TBC1D2B NBN PTK2 CDKAL1 RYR2 NF1 TIMELESS PACS1 SLC16A3 | 1.66e-05 | 194 | 215 | 10 | 4727_DN |
| Drug | ICI182,780; Up 200; 1uM; PC3; HT_HG-U133A | 1.74e-05 | 195 | 215 | 10 | 6918_UP | |
| Drug | Papaverine hydrochloride [61-25-6]; Up 200; 10.6uM; PC3; HT_HG-U133A | KIF1A TBC1D2B ARMCX1 URB1 ACSM3 TIMELESS PLD1 MLXIP TG SLC12A4 | 1.82e-05 | 196 | 215 | 10 | 5769_UP |
| Drug | Harmane hydrochloride [21655-84-5]; Up 200; 18.2uM; MCF7; HT_HG-U133A | 1.90e-05 | 197 | 215 | 10 | 4408_UP | |
| Drug | Ungerine nitrate; Down 200; 10.2uM; HL60; HT_HG-U133A | 1.90e-05 | 197 | 215 | 10 | 2514_DN | |
| Drug | fluo-3 | 2.13e-05 | 122 | 215 | 8 | CID000104978 | |
| Drug | folate polyglutamate | 2.67e-05 | 205 | 215 | 10 | CID000003405 | |
| Drug | Sy 2 | 2.83e-05 | 7 | 215 | 3 | CID000022260 | |
| Disease | Malignant neoplasm of breast | CD109 NBN COG3 TTC3 ABCB1 GJA1 NAA25 NF1 JMJD6 TIMELESS DPYD VWF PCDHB15 PPA1 PCDH20 SLC2A1 MSH6 SLC16A3 NUP133 ELK3 GABRA4 | 2.26e-05 | 1074 | 206 | 21 | C0006142 |
| Disease | acute lymphoblastic leukemia (is_implicated_in) | 4.14e-05 | 55 | 206 | 5 | DOID:9952 (is_implicated_in) | |
| Disease | Adenosine monophosphate deaminase deficiency | 4.85e-05 | 2 | 206 | 2 | C2931781 | |
| Disease | Muscle AMP deaminase deficiency | 4.85e-05 | 2 | 206 | 2 | C0268123 | |
| Disease | level of collagen alpha-1(X) chain in blood serum | 4.85e-05 | 2 | 206 | 2 | OBA_2041080 | |
| Disease | Developmental Disabilities | 5.48e-05 | 30 | 206 | 4 | C0008073 | |
| Disease | cutaneous melanoma, hair color | 7.40e-05 | 62 | 206 | 5 | EFO_0000389, EFO_0003924 | |
| Disease | Myoclonic Seizures | 9.25e-05 | 104 | 206 | 6 | C4317123 | |
| Disease | Colorectal Carcinoma | CD109 ABCB1 NF1 PDILT VPS13A ABCD3 DPYD AMPD1 HAT1 APOB PTPRU SLC1A7 PREX2 MSH6 PROS1 | 1.34e-04 | 702 | 206 | 15 | C0009402 |
| Disease | congenital myopathy 1A (implicated_via_orthology) | 1.45e-04 | 3 | 206 | 2 | DOID:3529 (implicated_via_orthology) | |
| Disease | malignant hyperthermia (implicated_via_orthology) | 1.45e-04 | 3 | 206 | 2 | DOID:8545 (implicated_via_orthology) | |
| Disease | Ataxia, Motor | 1.76e-04 | 16 | 206 | 3 | C0278161 | |
| Disease | Tremor, Rubral | 1.76e-04 | 16 | 206 | 3 | C0750940 | |
| Disease | Ataxia, Appendicular | 1.76e-04 | 16 | 206 | 3 | C0750937 | |
| Disease | Ataxia, Sensory | 1.76e-04 | 16 | 206 | 3 | C0240991 | |
| Disease | Abnormal coordination | 1.76e-04 | 16 | 206 | 3 | C0520966 | |
| Disease | Ataxia, Truncal | 1.76e-04 | 16 | 206 | 3 | C0427190 | |
| Disease | X-12125 measurement | 2.88e-04 | 4 | 206 | 2 | EFO_0800707 | |
| Disease | synucleinopathy (biomarker_via_orthology) | 2.88e-04 | 4 | 206 | 2 | DOID:0050890 (biomarker_via_orthology) | |
| Disease | hepatocellular carcinoma (is_implicated_in) | 2.94e-04 | 181 | 206 | 7 | DOID:684 (is_implicated_in) | |
| Disease | Liver Cirrhosis, Experimental | ZFYVE16 BCR ARMCX1 SLC39A8 IQGAP1 ABCB1 GJA1 ALB EZR VWF RBL2 DUSP6 MSN FRY LTA4H | 3.80e-04 | 774 | 206 | 15 | C0023893 |
| Disease | Profound Mental Retardation | 4.48e-04 | 139 | 206 | 6 | C0020796 | |
| Disease | Mental deficiency | 4.48e-04 | 139 | 206 | 6 | C0917816 | |
| Disease | Mental Retardation, Psychosocial | 4.48e-04 | 139 | 206 | 6 | C0025363 | |
| Disease | urethral obstruction (biomarker_via_orthology) | 4.78e-04 | 5 | 206 | 2 | DOID:12577 (biomarker_via_orthology) | |
| Disease | secondary hyperparathyroidism (is_marker_for) | 4.78e-04 | 5 | 206 | 2 | DOID:12466 (is_marker_for) | |
| Disease | pontocerebellar hypoplasia (implicated_via_orthology) | 4.78e-04 | 5 | 206 | 2 | DOID:0060264 (implicated_via_orthology) | |
| Disease | obsolete_red blood cell distribution width | ATR BACH1 MCM6 MIDEAS PTK2 SLC39A8 IQGAP1 ABCB1 MICU1 CYFIP1 DSTYK VPS13A PLD1 RBL1 APOB SERPINA2 SLC2A1 ZNF516 YLPM1 SMCR8 SLC16A10 | 5.15e-04 | 1347 | 206 | 21 | EFO_0005192 |
| Disease | nervous system disorder | 5.17e-04 | 53 | 206 | 4 | C0027765 | |
| Disease | Autistic Disorder | 5.24e-04 | 261 | 206 | 8 | C0004352 | |
| Disease | urate measurement | LGR4 MCM6 ADGRV1 SLC39A8 CDKAL1 NAA25 ACSM3 RRAGD SYT11 PDILT PRXL2A MLXIP PIGU ORC4 SPPL2A SLC16A10 | 5.86e-04 | 895 | 206 | 16 | EFO_0004531 |
| Disease | Liver Failure, Acute | 6.09e-04 | 24 | 206 | 3 | C0162557 | |
| Disease | Ataxia | 6.89e-04 | 25 | 206 | 3 | C0004134 | |
| Disease | coronary artery disease (is_implicated_in) | 6.95e-04 | 100 | 206 | 5 | DOID:3393 (is_implicated_in) | |
| Disease | Idiopathic generalized epilepsy | 7.14e-04 | 6 | 206 | 2 | C0270850 | |
| Disease | familial combined hyperlipidemia (is_marker_for) | 7.14e-04 | 6 | 206 | 2 | DOID:13809 (is_marker_for) | |
| Disease | AIDS dementia | 7.14e-04 | 6 | 206 | 2 | EFO_0002608 | |
| Disease | Generalized seizures | 7.27e-04 | 101 | 206 | 5 | C0234533 | |
| Disease | Clonic Seizures | 7.27e-04 | 101 | 206 | 5 | C0234535 | |
| Disease | Non-epileptic convulsion | 7.27e-04 | 101 | 206 | 5 | C0751056 | |
| Disease | Atonic Absence Seizures | 7.27e-04 | 101 | 206 | 5 | C0751123 | |
| Disease | Single Seizure | 7.27e-04 | 101 | 206 | 5 | C0751110 | |
| Disease | Visual seizure | 7.27e-04 | 101 | 206 | 5 | C0270824 | |
| Disease | Epileptic drop attack | 7.27e-04 | 101 | 206 | 5 | C0270846 | |
| Disease | Vertiginous seizure | 7.27e-04 | 101 | 206 | 5 | C0422855 | |
| Disease | Gustatory seizure | 7.27e-04 | 101 | 206 | 5 | C0422854 | |
| Disease | Seizures, Somatosensory | 7.27e-04 | 101 | 206 | 5 | C0422850 | |
| Disease | Olfactory seizure | 7.27e-04 | 101 | 206 | 5 | C0422853 | |
| Disease | Seizures, Auditory | 7.27e-04 | 101 | 206 | 5 | C0422852 | |
| Disease | Convulsive Seizures | 7.27e-04 | 101 | 206 | 5 | C0751494 | |
| Disease | Seizures, Sensory | 7.27e-04 | 101 | 206 | 5 | C0751496 | |
| Disease | Complex partial seizures | 7.27e-04 | 101 | 206 | 5 | C0149958 | |
| Disease | Nonepileptic Seizures | 7.27e-04 | 101 | 206 | 5 | C3495874 | |
| Disease | Generalized Absence Seizures | 7.27e-04 | 101 | 206 | 5 | C4505436 | |
| Disease | Jacksonian Seizure | 7.27e-04 | 101 | 206 | 5 | C0022333 | |
| Disease | gastroesophageal reflux disease | 7.27e-04 | 101 | 206 | 5 | EFO_0003948 | |
| Disease | Epileptic Seizures | 7.27e-04 | 101 | 206 | 5 | C4317109 | |
| Disease | Absence Seizures | 7.60e-04 | 102 | 206 | 5 | C4316903 | |
| Disease | Convulsions | 7.60e-04 | 102 | 206 | 5 | C4048158 | |
| Disease | Tonic Seizures | 7.60e-04 | 102 | 206 | 5 | C0270844 | |
| Disease | brain ischemia (biomarker_via_orthology) | 7.60e-04 | 102 | 206 | 5 | DOID:2316 (biomarker_via_orthology) | |
| Disease | schizophrenia, intelligence, self reported educational attainment | 7.74e-04 | 346 | 206 | 9 | EFO_0004337, EFO_0004784, MONDO_0005090 | |
| Disease | Tonic - clonic seizures | 8.30e-04 | 104 | 206 | 5 | C0494475 | |
| Disease | Seizures, Focal | 8.30e-04 | 104 | 206 | 5 | C0751495 | |
| Disease | cystic fibrosis (is_implicated_in) | 8.67e-04 | 27 | 206 | 3 | DOID:1485 (is_implicated_in) | |
| Disease | myeloid white cell count | KIF1B MCM6 FMNL2 CDKAL1 GJA1 BPI DSTYK AMPD3 ATP13A1 LRRK1 SLC2A1 PREX2 GALNT17 SPPL2A LNPEP ZNF516 | 9.51e-04 | 937 | 206 | 16 | EFO_0007988 |
| Disease | hereditary spastic paraplegia (is_implicated_in) | 9.95e-04 | 7 | 206 | 2 | DOID:2476 (is_implicated_in) | |
| Disease | triglycerides to total lipids in IDL percentage | 9.96e-04 | 63 | 206 | 4 | EFO_0022329 | |
| Disease | Depressive disorder | 1.02e-03 | 289 | 206 | 8 | C0011581 | |
| Disease | Child Development Disorders, Specific | 1.07e-03 | 29 | 206 | 3 | C0085997 | |
| Disease | Child Development Deviations | 1.07e-03 | 29 | 206 | 3 | C0085996 | |
| Disease | aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement | 1.10e-03 | 364 | 206 | 9 | EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946 | |
| Disease | hypertension (biomarker_via_orthology) | 1.13e-03 | 227 | 206 | 7 | DOID:10763 (biomarker_via_orthology) | |
| Disease | Myopathy | 1.18e-03 | 30 | 206 | 3 | C0026848 | |
| Disease | Crohn's disease (is_implicated_in) | 1.18e-03 | 30 | 206 | 3 | DOID:8778 (is_implicated_in) | |
| Disease | serum alanine aminotransferase measurement | BACH1 L2HGDH PANX1 RPS26 SLC39A8 GALNT13 ABCB1 NAA25 DSTYK EZR APOB MLXIP SERPINA2 PIGU ST6GALNAC3 | 1.23e-03 | 869 | 206 | 15 | EFO_0004735 |
| Disease | Intellectual Disability | 1.26e-03 | 447 | 206 | 10 | C3714756 | |
| Disease | arteriosclerosis (is_implicated_in) | 1.31e-03 | 31 | 206 | 3 | DOID:2349 (is_implicated_in) | |
| Disease | temporal lobe epilepsy (biomarker_via_orthology) | 1.31e-03 | 31 | 206 | 3 | DOID:3328 (biomarker_via_orthology) | |
| Disease | familial hyperlipidemia (is_implicated_in) | 1.32e-03 | 8 | 206 | 2 | DOID:1168 (is_implicated_in) | |
| Disease | LEUKEMIA, ACUTE LYMPHOBLASTIC | 1.32e-03 | 8 | 206 | 2 | 613065 | |
| Disease | Uveal melanoma | 1.32e-03 | 8 | 206 | 2 | C0220633 | |
| Disease | Acute lymphoid leukemia | 1.32e-03 | 8 | 206 | 2 | cv:C0023449 | |
| Disease | N2,N2-dimethylguanosine measurement | 1.32e-03 | 8 | 206 | 2 | EFO_0021125 | |
| Disease | Thrombophilia due to thrombin defect | 1.32e-03 | 8 | 206 | 2 | cv:C3160733 | |
| Disease | blood urea nitrogen measurement | PLPPR3 MCM6 ADGRV1 NAA25 PDILT PRXL2A MLXIP PIGU SLC1A7 SLC16A3 | 1.37e-03 | 452 | 206 | 10 | EFO_0004741 |
| Disease | cholesteryl esters to total lipids in very small VLDL percentage | 1.56e-03 | 71 | 206 | 4 | EFO_0022259 | |
| Disease | alpha-1-antitrypsin measurement | 1.69e-03 | 9 | 206 | 2 | EFO_0008327 | |
| Disease | symmetrical dimethylarginine measurement | 1.69e-03 | 9 | 206 | 2 | EFO_0006523 | |
| Disease | thoracic aortic calcification measurement | 1.69e-03 | 9 | 206 | 2 | EFO_0010273 | |
| Disease | free cholesterol to total lipids in large LDL percentage | 1.81e-03 | 74 | 206 | 4 | EFO_0022280 | |
| Disease | Borderline personality disorder | 1.86e-03 | 35 | 206 | 3 | HP_0012076 | |
| Disease | lung squamous cell carcinoma (is_marker_for) | 2.02e-03 | 36 | 206 | 3 | DOID:3907 (is_marker_for) | |
| Disease | Cardiovascular Diseases | 2.02e-03 | 36 | 206 | 3 | C0007222 | |
| Disease | metabolite measurement | PDXDC1 SETD1A MCM6 CDKAL1 MICU1 ALMS1 DMGDH LIPF WDFY4 AGXT2 YLPM1 | 2.05e-03 | 560 | 206 | 11 | EFO_0004725 |
| Disease | Malignant Neoplasms | 2.09e-03 | 128 | 206 | 5 | C0006826 | |
| Disease | diabetes mellitus biomarker | 2.10e-03 | 10 | 206 | 2 | EFO_0006842 | |
| Disease | 2-ketocaprylate measurement | 2.10e-03 | 10 | 206 | 2 | EFO_0800110 | |
| Disease | Glioblastoma | 2.30e-03 | 79 | 206 | 4 | C0017636 | |
| Disease | pulmonary hypertension (biomarker_via_orthology) | 2.41e-03 | 80 | 206 | 4 | DOID:6432 (biomarker_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LTFSVDYNFPKKALV | 161 | Q9BT88 | |
| VQYPKGFLKEAFELV | 296 | Q9BYV1 | |
| VKGFEPLIQFAYTAK | 81 | O14867 | |
| FFLLEKILTKYGVDP | 166 | Q6P093 | |
| IFAKFSAYIKNSRPE | 121 | Q9Y696 | |
| TPYKDIFAAFNTKFI | 316 | Q8N8Q8 | |
| PELLFFAKRYKAAFT | 176 | P02768 | |
| FAFSLYKQLVLKAPD | 56 | P01011 | |
| TETFAPILYVFKFKN | 426 | P49419 | |
| IFFKVPELYEIHKEF | 546 | P11274 | |
| CIFFNKIYIILFKPS | 851 | P41180 | |
| VFLQEKDQKYIFPTL | 501 | Q92974 | |
| YDALEKKQFLPVAFP | 181 | Q9HD20 | |
| PTLYLFVGENFKKVF | 296 | Q49SQ1 | |
| FGTFSVEEYVLPKFK | 206 | A8K2U0 | |
| TVGKPIKLLANYFEV | 31 | Q9UL18 | |
| YGIFIFSEKNRPVKV | 1976 | Q8WXG9 | |
| SSFGEKPIVIYKQAF | 1476 | Q8TCU4 | |
| IFELFAKNFSYGKPL | 26 | Q8IYT2 | |
| YGFFLEPKSTKKEIF | 666 | Q9P2G1 | |
| QGFYTSKDFLPLVAK | 301 | Q12882 | |
| YLLDRFAQPVTKDKF | 401 | A6QL64 | |
| FLEYAKNPFLDFLQK | 626 | P23109 | |
| KAFLLKFVNAYSPIF | 626 | Q9NQ90 | |
| EYSFKIFPEKNIRGF | 276 | P17813 | |
| LSTYIKFVNLFPEVK | 541 | O94973 | |
| IYDIFRSKKLLPNFG | 476 | Q01432 | |
| FILSSKGDPLIYKDF | 6 | O00189 | |
| KLSGYFVPFIVFVSI | 936 | Q04656 | |
| VYLAKLGNFFSPKVV | 76 | P46940 | |
| YIKAFCKGFFVAVPV | 11 | Q96T52 | |
| FVKKIDAAVFNPRFY | 376 | P39900 | |
| LPFVLKPTFKNFYAL | 336 | Q96TA0 | |
| PEIFLGFLKAYVEKF | 401 | P09960 | |
| AAYEIFKIIDNKPSI | 361 | P08183 | |
| FFFFLDPLRTGKIKI | 226 | Q969Q6 | |
| FTVSAVIFKKYEPIF | 156 | Q08999 | |
| VIFKKYEPIFQDIFK | 161 | Q08999 | |
| ITFLIAQEKEFPKFF | 1461 | O00763 | |
| FGFPQYVKIFKEQLS | 221 | O43929 | |
| YVKIFKEQLSLPAEF | 226 | O43929 | |
| DKYFKQLQVVPLFGD | 296 | Q7L576 | |
| ITPIAGDYILFKFDK | 421 | Q9UM21 | |
| GDYILFKFDKPVNVE | 426 | Q9UM21 | |
| VVQPGKLTEAFKYFL | 296 | Q9UGV2 | |
| LGSLKSNPYFEFVLK | 1131 | Q8WUM0 | |
| IAFFTIRDPEGKYKV | 451 | Q8N6Y1 | |
| RKEIPLAKDFYVAFQ | 101 | Q14566 | |
| KVPKFFTDDLFQYAG | 151 | Q6NYC1 | |
| PLIYNSFAQFLVKEK | 31 | Q5TFE4 | |
| YPVKIKVRFSFFLQI | 316 | Q9P035 | |
| LVLFFIFTYFKVPET | 441 | P11166 | |
| CFLGATVKYLQKFIP | 376 | Q9H9P8 | |
| YAFPKAVSVFFKELI | 36 | O15427 | |
| YFQFLAKFEIALPVA | 971 | Q38SD2 | |
| KYAPIFESDFIQITK | 41 | Q8IYT1 | |
| ITILKVFFPVSEYKG | 281 | Q9NU53 | |
| VDYIKTKPIVFEVFG | 1181 | O60333 | |
| IKIFFALAPVFSTKY | 161 | Q5W064 | |
| KFKGSFLIYPESEAV | 1216 | A9Z1Z3 | |
| KIFRYFATLKVISEP | 126 | Q9BPX6 | |
| FVPQSLFKFIFGDKI | 216 | P07098 | |
| SQFIGYPITLFVEKK | 41 | Q58FG0 | |
| KFKLYGITFTNPLVF | 1096 | Q96RV3 | |
| YKQDFFLKRFPQTVL | 11 | Q63HM2 | |
| PIKSLDKFLAVFYSV | 256 | Q8NH21 | |
| FVVDGFNVLYNKKPV | 161 | Q6P996 | |
| EKLFSKPTYAAFINL | 191 | P21128 | |
| KPGEYVIKSLFAEFA | 11 | O94915 | |
| TGIFPLSFVKILKDF | 216 | Q15080 | |
| ANITFYTGVPKAEFK | 556 | P00488 | |
| FDEPAFKATFIIKII | 306 | Q9UIQ6 | |
| LNPVLYVFFNPKFKE | 796 | Q9BXB1 | |
| LLFKFRAKFYPEDVS | 76 | P26038 | |
| SKIDKYARILFPVTF | 516 | P48169 | |
| LFTPAVLEKYNVVFK | 466 | Q9UGJ1 | |
| SVDRFLAIVYPFKSK | 111 | P43657 | |
| PKLKTVLFVVFFAIY | 21 | A6NET4 | |
| PIKSLDKFLAVFYSV | 256 | Q8NGA8 | |
| FVPFRQKTDVLKVYE | 296 | Q96RD7 | |
| FKLKPSVENFYRLVT | 391 | Q9Y5E8 | |
| ETITFLYKFIKGACP | 1281 | P52701 | |
| NVFFYTIPLAIKLKE | 296 | Q9H490 | |
| VFFFKVPKLGSEIID | 276 | Q6XUX3 | |
| SYQKFIPFIGVVKVG | 741 | Q6VY07 | |
| KGQLFPLAKEFIDQY | 356 | P29475 | |
| VDVFFAAKTLRNYKP | 1406 | Q92729 | |
| FKDFFYIISPGVVKV | 376 | Q8IUC8 | |
| KFKQVFDTTLLAEYP | 236 | Q5VZV1 | |
| LQYPSIVTKAFVFKA | 136 | Q8NH76 | |
| LKLGFESIYKIPFAD | 176 | P49643 | |
| IFSIIIKPLFESFKG | 836 | Q9HAP2 | |
| QFVAYFLPVEETLKK | 256 | Q8N7H5 | |
| QVDKFFPLIEVNKVY | 241 | P27694 | |
| EFKNFFYIISPGVTK | 376 | Q10472 | |
| FVKDILFPYIEENVK | 26 | Q9UHY7 | |
| KEYITNFPLFIGKVV | 401 | P20848 | |
| VEKPQEFTIVAFVKY | 2046 | P04114 | |
| GYSFSIPVKVLADKF | 3716 | P04114 | |
| SKLIKTLFPFEAEAY | 296 | Q13535 | |
| VKFRIVTLFSDFKPY | 146 | Q6YHK3 | |
| FVFDLPLQVKIKTFY | 1286 | Q711Q0 | |
| YFLNKPIIFGDFIKF | 2366 | Q9C0G6 | |
| PRYKFNFIADVVEKI | 136 | P83110 | |
| FLSLLEKEVDFKPFG | 126 | O14929 | |
| KKPDVLLYDTIFQIF | 281 | P51878 | |
| YFFITKKNPIVFIRG | 316 | O00341 | |
| GLFKPFVESYQIICK | 571 | O15228 | |
| ETVKLVEEYKFPSLF | 376 | Q5VV42 | |
| YLSNKDTEFILFKPV | 771 | Q96JB2 | |
| FIALTVKEKYPDLAN | 811 | Q8IVF7 | |
| TKFFGTFLPEVAKKF | 326 | P17213 | |
| IELFYVFFKGVKDRV | 226 | P17302 | |
| KYSKDLPQISIIFIF | 146 | Q6IS24 | |
| FPVFVRFVKAYKQAE | 971 | Q96PY5 | |
| IGQKFVYKFVSFPEI | 76 | P41970 | |
| ILVKYPTFQDKTLNF | 536 | Q6ZN28 | |
| GLEYFVKLNKPADFI | 741 | Q9UI17 | |
| FNKGIAIYKKDFFLV | 841 | Q6PJG2 | |
| APFSLEYRVFLKNEK | 11 | Q15181 | |
| KKGDLFIFFDIQFPT | 286 | P59910 | |
| FFKLKESQLPALAIY | 211 | Q96DN0 | |
| KTGFEIGFLVLFYKL | 131 | Q6PEY0 | |
| EFIEKARIKYGPIFT | 51 | Q9NYL5 | |
| LFAPAAIVPKDKVFY | 111 | Q08477 | |
| LQFKFRAKFYPEDVA | 76 | P15311 | |
| KPGEYVLKSLFVNFT | 61 | Q5TBA9 | |
| GYVIIKKPLDFETAA | 511 | Q12864 | |
| LFENAGEFKYKQIPI | 246 | Q16828 | |
| GIEKAFLFDVVSKIY | 256 | Q9NQL2 | |
| EAIANYVKEFSPKLV | 211 | O75880 | |
| YEQEIKFFAKVVLPL | 2956 | Q92736 | |
| KFFAKVVLPLIDQYF | 2961 | Q92736 | |
| FIYFPQIKTEKSGSI | 141 | Q96FZ2 | |
| KSFIEYIKSQPIVFE | 1061 | Q12756 | |
| PFLVAFKEIYKCTLI | 211 | A6NK58 | |
| LLPFKKGAFYLAVQA | 181 | O15120 | |
| SFIKIPVGKEEFVYI | 2266 | Q12923 | |
| PIKSLDKFLAVFYSV | 256 | Q96R69 | |
| QEFGITKAPELKLFF | 111 | Q8N807 | |
| AVYIFAKKNDIPFEL | 16 | P30711 | |
| FVKIANFSYPLFLKL | 136 | P59534 | |
| LSYNTKFAIPDFKVG | 31 | Q8NEY4 | |
| AIAFLTLGYFFKIKE | 31 | Q9NWD8 | |
| IDQRKIFTFAEKYLP | 186 | P54577 | |
| FGKQLVVSYFPDKVA | 126 | Q96HV5 | |
| AKEKDIVYPGIAVFF | 121 | O95807 | |
| IEKSYKSIFVLSPNF | 686 | Q9BXR5 | |
| IVKPEYFTEFLKAVE | 171 | O60934 | |
| ELKKIRGFLVQFPFY | 1036 | Q13393 | |
| VSTVIFKKYEPIFLD | 131 | P28749 | |
| FKKYEPIFLDIFQNP | 136 | P28749 | |
| LFFLVSVIYKKFQLG | 206 | Q8WUX1 | |
| LKFFEILSPVYRFDK | 241 | Q05397 | |
| ITEFLGQPYFEAFKK | 226 | Q6NW34 | |
| PLISFKFGQKIFYVN | 176 | Q07960 | |
| TSVPLLLKNPDYFFK | 131 | Q8NDV1 | |
| KKAEYQLEPGTFFLF | 96 | Q14940 | |
| VLKIAPEYAIKFSVF | 156 | Q8N5S1 | |
| AKLAVQKYEELFPAF | 221 | P54920 | |
| FHEVSVYPKKELPFF | 501 | Q9NRC1 | |
| VYPKKELPFFILFTA | 506 | Q9NRC1 | |
| LETKVYFAGFPRKVE | 421 | P07225 | |
| YFAGFPRKVESELIK | 426 | P07225 | |
| HLVFKKIPYEEFFGQ | 1051 | Q13972 | |
| FKLDEFYIGQIPLKE | 81 | O15047 | |
| VCPDLLNKYFKEVTF | 366 | O60287 | |
| LNKYFKEVTFSFIPR | 371 | O60287 | |
| VKDFQPYFKGEIFLD | 121 | Q9BRX8 | |
| DGFLLPKYFKEALQL | 206 | Q86TN4 | |
| VFVGVKYVNKFASLF | 266 | Q9UP95 | |
| AYPKLNFVEDSKVVL | 111 | Q8TEV9 | |
| NLSKPFLDIVLYIFK | 206 | P28288 | |
| KLGIPEYFNFAKDVL | 51 | Q53FZ2 | |
| KPLFEEFGKIYELTV | 71 | Q9BZC1 | |
| KFNFPYKIDDILSAP | 191 | Q9P291 | |
| PILYVLISKKFQARF | 301 | P46091 | |
| QFFIPYTIKSKGIAV | 41 | Q03692 | |
| VKSIKDYGVFIQFPS | 736 | Q14690 | |
| LVTFAKYILGKFFAL | 766 | Q9UNS1 | |
| DILNIFKTYIPKDFA | 1056 | Q92618 | |
| YKLITFICEIFPEKI | 981 | Q9C0E2 | |
| FKIRFEVPKVLIEFY | 881 | Q96RL7 | |
| LIIIFKFSTKVPTFY | 656 | Q7RTX1 | |
| KIVIPVFNLFVKDIY | 376 | Q8N9B8 | |
| LKYTLFQIFSKIDRP | 1361 | P04275 | |
| DLPIYVKTVFAKGAA | 2011 | O75970 | |
| LQAAFSQYKKVELFP | 241 | P35247 | |
| PDSLLPNIFFTIKYK | 71 | Q9Y5W7 | |
| GYKFFTPILESKFKV | 321 | Q9H310 | |
| LYFLELTDLFKPAKV | 36 | Q6T4P5 | |
| GERKCLTFYLPKFFI | 406 | Q9P2C4 | |
| IKFFAKVLLPLVDQY | 2856 | Q15413 | |
| FLKPDDIQYFDKLLV | 466 | O75533 | |
| IVEDPDKFYIFKTIL | 371 | Q86TD4 | |
| VLYNKFITLFVEKLP | 76 | Q96FJ0 | |
| PDVKILIAFISYKDF | 131 | Q8TCT8 | |
| PFTFFDVQKTKYLQI | 221 | Q8NE00 | |
| KVFDSITYPQLEGFK | 356 | Q6ZS81 | |
| KIQIYITDPDFKGFI | 661 | P53804 | |
| FSLPKFYLLFGISKV | 2156 | P21359 | |
| ALFDLEKVSFYFKPS | 1341 | Q70Z35 | |
| GFFVRYFPSEDQKKL | 301 | Q4ZJI4 | |
| SNDPVLKFFKAYGVL | 36 | Q8NDW8 | |
| TFKKTLDDGFFPFII | 1916 | P49750 | |
| ASVFDAYVLPKLYVK | 56 | P62854 | |
| SYFPKILTFFVGLAI | 156 | Q9C0K1 | |
| FKIPFFQKIFKEEYR | 281 | Q9H0C3 | |
| TERIYFQVFLPKGSK | 161 | Q8TCF1 | |
| FEFFIEDFKTYKPLL | 81 | Q2TAA8 | |
| PGLEQYAIKKFAEAF | 431 | P50990 | |
| ILEDKVKNFYTRLPF | 1956 | P01266 | |
| GPKVIFRFALALFKY | 856 | Q9UPU7 | |
| YIFKDSFQFDLKPVG | 786 | P15822 | |
| RFASFPDYLVIQIKK | 561 | P45974 | |
| PDYLVIQIKKFTFGL | 566 | P45974 | |
| SFPEYLVVQIKKFTF | 576 | Q92995 | |
| FYKELGKLLDTFFQI | 116 | P0DTE5 | |
| PKDIFRLFITIYKDA | 1111 | Q7Z3T8 | |
| FFLKVTALTQKPDVY | 136 | A6NMB1 | |
| QYISKPLLIDGFKFD | 231 | A6NNM8 | |
| VKKVYLQVLSFFFIG | 356 | Q8TF71 | |
| AKYDLPATINFIIEK | 146 | Q5VXJ0 | |
| YEKNKTFFLEIGEPR | 616 | P32418 | |
| IKISPALEDFVYKIF | 486 | Q8IZF0 | |
| ENDYKFGLTKVFFRP | 746 | Q9UM54 | |
| KYGAFEKIPEFIAFR | 586 | Q14CX7 |